Q1 2026 --12-31 false 0001173489 0 0 http://fasb.org/us-gaap/2026#OperatingExpenses 1 1 3 4 1 1 1 0 0 1 1 0.75 0 0 0 0 0001173489 2026-01-01 2026-03-31 thunderdome:item xbrli:shares 0001173489 2026-03-31 0001173489 2025-01-01 2025-03-31 iso4217:USD 0001173489 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-01-01 2025-03-31 0001173489 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2026-01-01 2026-03-31 0001173489 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001173489 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-03-31 0001173489 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2025-03-31 0001173489 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001173489 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2026-03-31 0001173489 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2026-03-31 0001173489 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001173489 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-01-01 2025-03-31 0001173489 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2025-01-01 2025-03-31 0001173489 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001173489 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2026-01-01 2026-03-31 0001173489 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2026-01-01 2026-03-31 0001173489 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001173489 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-12-31 0001173489 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-12-31 0001173489 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001173489 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-12-31 0001173489 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2025-12-31 0001173489 us-gaap:ForeignExchangeForwardMember 2025-01-01 2025-03-31 0001173489 us-gaap:ForeignExchangeForwardMember 2026-01-01 2026-03-31 0001173489 us-gaap:ForeignExchangeOptionMember 2025-01-01 2025-03-31 0001173489 us-gaap:ForeignExchangeOptionMember 2026-01-01 2026-03-31 0001173489 us-gaap:CashFlowHedgingMember 2025-01-01 2025-03-31 0001173489 us-gaap:CashFlowHedgingMember 2026-01-01 2026-03-31 0001173489 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2025-01-01 2025-03-31 0001173489 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2026-01-01 2026-03-31 0001173489 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember 2025-01-01 2025-03-31 0001173489 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember 2026-01-01 2026-03-31 0001173489 us-gaap:CashFlowHedgingMember 2025-12-31 0001173489 us-gaap:CashFlowHedgingMember 2026-03-31 0001173489 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember 2025-12-31 0001173489 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember 2026-03-31 0001173489 2025-12-31 0001173489 ceva:The2002EmployeeStockPurchasePlanMember 2025-01-01 2025-03-31 iso4217:USD xbrli:shares 0001173489 ceva:The2002EmployeeStockPurchasePlanMember 2025-03-31 0001173489 ceva:The2002EmployeeStockPurchasePlanMember 2026-01-01 2026-03-31 0001173489 ceva:The2002EmployeeStockPurchasePlanMember 2026-03-31 utr:M 0001173489 ceva:PurchaseRightsMember ceva:The2002EmployeeStockPurchasePlanMember srt:MaximumMember 2025-01-01 2025-03-31 0001173489 ceva:PurchaseRightsMember ceva:The2002EmployeeStockPurchasePlanMember srt:MinimumMember 2025-01-01 2025-03-31 0001173489 ceva:PurchaseRightsMember ceva:The2002EmployeeStockPurchasePlanMember srt:MaximumMember 2026-01-01 2026-03-31 0001173489 ceva:PurchaseRightsMember ceva:The2002EmployeeStockPurchasePlanMember srt:MinimumMember 2026-01-01 2026-03-31 xbrli:pure 0001173489 ceva:PurchaseRightsMember ceva:The2002EmployeeStockPurchasePlanMember 2025-01-01 2025-03-31 0001173489 ceva:PurchaseRightsMember ceva:The2002EmployeeStockPurchasePlanMember 2026-01-01 2026-03-31 0001173489 us-gaap:GeneralAndAdministrativeExpense 2025-01-01 2025-03-31 0001173489 us-gaap:GeneralAndAdministrativeExpense 2026-01-01 2026-03-31 0001173489 us-gaap:SellingAndMarketingExpense 2025-01-01 2025-03-31 0001173489 us-gaap:SellingAndMarketingExpense 2026-01-01 2026-03-31 0001173489 us-gaap:ResearchAndDevelopmentExpense 2025-01-01 2025-03-31 0001173489 us-gaap:ResearchAndDevelopmentExpense 2026-01-01 2026-03-31 0001173489 us-gaap:CostOfRevenue 2025-01-01 2025-03-31 0001173489 us-gaap:CostOfRevenue 2026-01-01 2026-03-31 utr:Y 0001173489 ceva:RSUsAndPSUsMember 2026-01-01 2026-03-31 0001173489 ceva:RSUsAndPSUsMember 2026-03-31 0001173489 ceva:RSUsAndPSUsMember 2025-12-31 0001173489 ceva:ShorttermExecutivePSUsMember ceva:VestingOnFebruary192029Member 2026-02-11 2026-02-11 0001173489 ceva:ShorttermExecutivePSUsMember ceva:VestingOnFebruary192028Member 2026-02-11 2026-02-11 0001173489 ceva:ShorttermExecutivePSUsMember ceva:VestingOnFebruary192027Member 2026-02-11 2026-02-11 0001173489 ceva:PerformanceShareUnitsMember ceva:The2011StockIncentivePlanMember ceva:GoalsThreeMember 2026-02-11 2026-02-11 0001173489 ceva:PerformanceShareUnitsMember ceva:The2011StockIncentivePlanMember ceva:GoalsTwoMember 2026-02-11 2026-02-11 0001173489 ceva:PerformanceShareUnitsMember ceva:The2011StockIncentivePlanMember ceva:GoalsOneMember 2026-02-11 2026-02-11 0001173489 ceva:PerformanceShareUnitsMember ceva:The2011StockIncentivePlanMember 2026-02-11 2026-02-11 0001173489 ceva:PerformanceShareUnitsMember ceva:The2011StockIncentivePlanMember srt:ExecutiveOfficerMember 2026-02-11 2026-02-11 0001173489 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedPaymentArrangementNonemployeeMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2026-01-01 2026-03-31 0001173489 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2026-01-01 2026-03-31 0001173489 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2026-01-01 2026-03-31 0001173489 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001173489 us-gaap:EmployeeStockOptionMember 2026-03-31 0001173489 2025-01-01 2025-12-31 0001173489 us-gaap:EmployeeStockOptionMember us-gaap:ShareBasedPaymentArrangementNonemployeeMember ceva:The2011StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2026-01-01 2026-03-31 0001173489 us-gaap:EmployeeStockOptionMember us-gaap:ShareBasedPaymentArrangementEmployeeMember ceva:The2011StockIncentivePlanMember srt:MaximumMember 2026-01-01 2026-03-31 0001173489 us-gaap:EmployeeStockOptionMember us-gaap:ShareBasedPaymentArrangementEmployeeMember ceva:The2011StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2026-01-01 2026-03-31 0001173489 us-gaap:EmployeeStockOptionMember us-gaap:ShareBasedPaymentArrangementEmployeeMember ceva:The2011StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2026-01-01 2026-03-31 0001173489 us-gaap:EmployeeStockOptionMember ceva:The2011StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2026-01-01 2026-03-31 0001173489 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember ceva:CustomerAMember 2025-01-01 2025-12-31 0001173489 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember ceva:CustomerAMember 2026-01-01 2026-03-31 0001173489 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember ceva:CustomerCMember 2026-01-01 2026-03-31 0001173489 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember ceva:CustomerBMember 2026-01-01 2026-03-31 0001173489 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember ceva:CustomerAMember 2025-01-01 2025-03-31 0001173489 ceva:OtherGeographicRegionsMember 2025-12-31 0001173489 ceva:OtherGeographicRegionsMember 2026-03-31 0001173489 country:GR 2025-12-31 0001173489 country:GR 2026-03-31 0001173489 country:US 2025-12-31 0001173489 country:US 2026-03-31 0001173489 country:FR 2025-12-31 0001173489 country:FR 2026-03-31 0001173489 country:IL 2025-12-31 0001173489 country:IL 2026-03-31 0001173489 country:CN 2025-01-01 2025-03-31 0001173489 country:CN 2026-01-01 2026-03-31 0001173489 srt:AsiaPacificMember 2025-01-01 2025-03-31 0001173489 srt:AsiaPacificMember 2026-01-01 2026-03-31 0001173489 ceva:EuropeAndMiddleEastMember 2025-01-01 2025-03-31 0001173489 ceva:EuropeAndMiddleEastMember 2026-01-01 2026-03-31 0001173489 country:US 2025-01-01 2025-03-31 0001173489 country:US 2026-01-01 2026-03-31 0001173489 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001173489 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001173489 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001173489 us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001173489 ceva:CorporateBondsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001173489 ceva:CorporateBondsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001173489 ceva:CorporateBondsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001173489 ceva:CorporateBondsMember us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001173489 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001173489 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001173489 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001173489 us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001173489 ceva:CorporateBondsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001173489 ceva:CorporateBondsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001173489 ceva:CorporateBondsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001173489 ceva:CorporateBondsMember us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001173489 ceva:CorporateBondsMember 2025-12-31 0001173489 ceva:CorporateBondsMember 2026-03-31 0001173489 2024-12-31 0001173489 ceva:LicensingAndOtherMember 2024-12-31 0001173489 ceva:LicensingAndOtherMember 2026-03-31 0001173489 us-gaap:RoyaltyMember 2024-12-31 0001173489 us-gaap:RoyaltyMember 2026-03-31 0001173489 us-gaap:TradeAccountsReceivableMember 2024-12-31 0001173489 us-gaap:TradeAccountsReceivableMember 2026-03-31 0001173489 us-gaap:RoyaltyMember 2025-01-01 2025-03-31 0001173489 us-gaap:LicenseMember 2025-01-01 2025-03-31 0001173489 us-gaap:RoyaltyMember 2026-01-01 2026-03-31 0001173489 us-gaap:LicenseMember 2026-01-01 2026-03-31 0001173489 us-gaap:TransferredOverTimeMember 2025-01-01 2025-03-31 0001173489 us-gaap:LicenseMember us-gaap:TransferredOverTimeMember 2025-01-01 2025-03-31 0001173489 us-gaap:TransferredOverTimeMember 2026-01-01 2026-03-31 0001173489 us-gaap:LicenseMember us-gaap:TransferredOverTimeMember 2026-01-01 2026-03-31 0001173489 us-gaap:TransferredAtPointInTimeMember 2025-01-01 2025-03-31 0001173489 us-gaap:RoyaltyMember us-gaap:TransferredAtPointInTimeMember 2025-01-01 2025-03-31 0001173489 us-gaap:LicenseMember us-gaap:TransferredAtPointInTimeMember 2025-01-01 2025-03-31 0001173489 us-gaap:TransferredAtPointInTimeMember 2026-01-01 2026-03-31 0001173489 us-gaap:RoyaltyMember us-gaap:TransferredAtPointInTimeMember 2026-01-01 2026-03-31 0001173489 us-gaap:LicenseMember us-gaap:TransferredAtPointInTimeMember 2026-01-01 2026-03-31 0001173489 ceva:SmartSensingProductsMember 2025-01-01 2025-03-31 0001173489 us-gaap:RoyaltyMember ceva:SmartSensingProductsMember 2025-01-01 2025-03-31 0001173489 us-gaap:LicenseMember ceva:SmartSensingProductsMember 2025-01-01 2025-03-31 0001173489 ceva:SmartSensingProductsMember 2026-01-01 2026-03-31 0001173489 us-gaap:RoyaltyMember ceva:SmartSensingProductsMember 2026-01-01 2026-03-31 0001173489 us-gaap:LicenseMember ceva:SmartSensingProductsMember 2026-01-01 2026-03-31 0001173489 ceva:ConnectivityProductsMember 2025-01-01 2025-03-31 0001173489 us-gaap:RoyaltyMember ceva:ConnectivityProductsMember 2025-01-01 2025-03-31 0001173489 us-gaap:LicenseMember ceva:ConnectivityProductsMember 2025-01-01 2025-03-31 0001173489 ceva:ConnectivityProductsMember 2026-01-01 2026-03-31 0001173489 us-gaap:RoyaltyMember ceva:ConnectivityProductsMember 2026-01-01 2026-03-31 0001173489 us-gaap:LicenseMember ceva:ConnectivityProductsMember 2026-01-01 2026-03-31 0001173489 us-gaap:RoyaltyMember srt:AsiaPacificMember 2025-01-01 2025-03-31 0001173489 us-gaap:LicenseMember srt:AsiaPacificMember 2025-01-01 2025-03-31 0001173489 us-gaap:RoyaltyMember srt:AsiaPacificMember 2026-01-01 2026-03-31 0001173489 us-gaap:LicenseMember srt:AsiaPacificMember 2026-01-01 2026-03-31 0001173489 us-gaap:RoyaltyMember ceva:EuropeAndMiddleEastMember 2025-01-01 2025-03-31 0001173489 us-gaap:LicenseMember ceva:EuropeAndMiddleEastMember 2025-01-01 2025-03-31 0001173489 us-gaap:RoyaltyMember ceva:EuropeAndMiddleEastMember 2026-01-01 2026-03-31 0001173489 us-gaap:LicenseMember ceva:EuropeAndMiddleEastMember 2026-01-01 2026-03-31 0001173489 us-gaap:RoyaltyMember country:US 2025-01-01 2025-03-31 0001173489 us-gaap:LicenseMember country:US 2025-01-01 2025-03-31 0001173489 us-gaap:RoyaltyMember country:US 2026-01-01 2026-03-31 0001173489 us-gaap:LicenseMember country:US 2026-01-01 2026-03-31 0001173489 2028-01-01 2026-03-31 0001173489 2027-01-01 2026-03-31 0001173489 2026-04-01 2026-03-31 0001173489 2025-03-31 0001173489 us-gaap:RetainedEarningsMember 2025-03-31 0001173489 us-gaap:TreasuryStockCommonMember 2025-03-31 0001173489 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001173489 ceva:CommonStockOutstandingMember 2025-03-31 0001173489 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001173489 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0001173489 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001173489 ceva:CommonStockOutstandingMember 2025-01-01 2025-03-31 0001173489 us-gaap:RetainedEarningsMember 2024-12-31 0001173489 us-gaap:TreasuryStockCommonMember 2024-12-31 0001173489 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001173489 ceva:CommonStockOutstandingMember 2024-12-31 0001173489 us-gaap:RetainedEarningsMember 2026-03-31 0001173489 us-gaap:TreasuryStockCommonMember 2026-03-31 0001173489 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001173489 ceva:CommonStockOutstandingMember 2026-03-31 0001173489 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001173489 us-gaap:TreasuryStockCommonMember 2026-01-01 2026-03-31 0001173489 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001173489 ceva:CommonStockOutstandingMember 2026-01-01 2026-03-31 0001173489 us-gaap:RetainedEarningsMember 2025-12-31 0001173489 us-gaap:TreasuryStockCommonMember 2025-12-31 0001173489 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001173489 ceva:CommonStockOutstandingMember 2025-12-31 0001173489 2026-05-05

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

| For the quarterly period ended: March 31, 2026

OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

| For the transition period from __________ to _____________

Commission file number: 000-49842

Ceva, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware | 77-0556376
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.)
15245 Shady Grove Road, Suite 400, Rockville, MD 20850 | 20850
(Address of Principal Executive Offices) | (Zip Code)

(240)-308-8328

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, $.001 per share | CEVA | Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

1

Table of Contents

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☐ | Accelerated filer | ☒
Non-accelerated filer | ☐ | Smaller reporting company | ☐
Emerging growth company | ☐ |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date: 27,859,369 of common stock, $0.001 par value, as of May 5, 2026.

2

Table of Contents

TABLE OF CONTENTS

| Page
PART I. | FINANCIAL INFORMATION | 5
Item 1. | Interim Condensed Consolidated Balance Sheets at March 31, 2026 (unaudited) and December 31, 2025 | 5
| Interim Condensed Consolidated Statements of Loss (unaudited) for the three months ended March 31, 2026 and 2025 | 6
| Interim Condensed Consolidated Statements of Comprehensive Loss (unaudited) for the three months ended March 31, 2026 and 2025 | 7
| Interim Condensed Consolidated Statements of Changes in Stockholders’ Equity (unaudited) for the three months ended March 31, 2026 and 2025 | 8
| Interim Condensed Consolidated Statements of Cash Flows (unaudited) for the three months ended March 31, 2026 and 2025 | 9
| Notes to the Interim Condensed Consolidated Financial Statements | 10
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 26
Item 3. | Quantitative and Qualitative Disclosures about Market Risk | 35
Item 4. | Controls and Procedures | 36
PART II. | OTHER INFORMATION | 36
Item 1. | Legal Proceedings | 36
Item 1A. | Risk Factors | 37
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 38
Item 3. | Defaults Upon Senior Securities | 38
Item 4. | Mine Safety Disclosures | 38
Item 5. | Other Information | 38
Item 6. | Exhibits | 39
SIGNATURES | 39

3

Table of Contents

FORWARD-LOOKING STATEMENTS

This Quarterly Report contains forward-looking statements which are based on our management’s beliefs and assumptions and on information currently available to our management. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “goal,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “project,” “predict,” “potential,” and similar expressions intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results, performance, time frames or achievements to be materially different from any future results, performance, time frames or achievements expressed or implied by the forward-looking statements. We discuss these risks, uncertainties and other factors in this Quarterly Report and our Annual Report on Form 10-K for the year ended December 31, 2025 in greater detail under the heading “Risk Factors” of such reports. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of this filing. You should read this Quarterly Report completely and with the understanding that our actual future results may be materially different from what we expect. We hereby qualify our forward-looking statements by these cautionary statements. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the filing date of this Quarterly Report, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

4

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

U.S. dollars in thousands, except share and per share data

|  | March 31, 2026 |  |  | December 31, 2025 |
ASSETS |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 21,367 |  |  | $ | 40,586 |
Short-term bank deposits |  |  | 5,136 |  |  |  | 2,095 |
Marketable securities |  |  | 189,190 |  |  |  | 179,302 |
Trade receivables (net of allowance for credit losses of $288 at both March 31, 2026 and December 31, 2025) |  |  | 48,872 |  |  |  | 49,355 |
Prepaid expenses and other current assets |  |  | 16,297 |  |  |  | 13,498 |
Total current assets |  |  | 280,862 |  |  |  | 284,836 |
Long-term assets: |  |  |  |  |  |  |  |
Severance pay fund |  |  | 7,225 |  |  |  | 7,530 |
Deferred tax assets, net |  |  | 274 |  |  |  | 257 |
Property and equipment, net |  |  | 9,010 |  |  |  | 7,054 |
Operating lease right-of-use assets |  |  | 17,190 |  |  |  | 17,486 |
Goodwill |  |  | 58,308 |  |  |  | 58,308 |
Intangible assets, net |  |  | 868 |  |  |  | 1,044 |
Investments in marketable equity securities |  |  | 119 |  |  |  | 55 |
Other long-term assets |  |  | 14,370 |  |  |  | 11,686 |
Total long-term assets |  |  | 107,364 |  |  |  | 103,420 |
Total assets |  | $ | 388,226 |  |  | $ | 388,256 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |
Trade payables |  | $ | 2,388 |  |  | $ | 2,418 |
Deferred revenues |  |  | 2,968 |  |  |  | 3,496 |
Accrued expenses and other payables |  |  | 4,298 |  |  |  | 5,181 |
Accrued payroll and related benefits |  |  | 14,926 |  |  |  | 15,845 |
Operating lease liabilities |  |  | 2,794 |  |  |  | 1,743 |
Total current liabilities |  |  | 27,374 |  |  |  | 28,683 |
Long-term liabilities: |  |  |  |  |  |  |  |
Accrued severance pay |  |  | 7,428 |  |  |  | 7,690 |
Operating lease liabilities |  |  | 14,083 |  |  |  | 14,388 |
Other accrued liabilities |  |  | 1,158 |  |  |  | 1,037 |
Total long-term liabilities |  |  | 22,669 |  |  |  | 23,115 |
Stockholders’ equity: |  |  |  |  |  |  |  |
Preferred Stock, $0.001 par value; 5,000,000 shares authorized; none issued and outstanding |  |  | — |  |  |  | — |
Common Stock, $0.001 par value; 45,000,000 shares authorized; 27,859,369 and 27,583,325 shares issued at March 31, 2026 and December 31, 2025, respectively; 27,859,369 and 27,510,739 shares outstanding at March 31, 2026 and December 31, 2025, respectively |  |  | 28 |  |  |  | 28 |
Additional paid-in capital |  |  | 343,298 |  |  |  | 337,966 |
Treasury stock at cost (0 and 72,586 shares of common stock at March 31, 2026 and December 31, 2025, respectively) |  |  | — |  |  |  | (1,591 | )
Accumulated other comprehensive income (loss) |  |  | (660 | ) |  |  | 79 |
Accumulated deficit |  |  | (4,483 | ) |  |  | (24 | )
Total stockholders’ equity |  |  | 338,183 |  |  |  | 336,458 |
Total liabilities and stockholders’ equity |  | $ | 388,226 |  |  | $ | 388,256 |

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

5

Table of Contents

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF LOSS (UNAUDITED)

U.S. dollars in thousands, except per share data

|  | Three months ended |
|  | March 31, |
|  | 2026 |  |  | 2025 |
Revenues: |  |  |  |  |  |  |  |
Licensing and related revenues |  | $ | 17,820 |  |  | $ | 15,042 |
Royalties |  |  | 9,204 |  |  |  | 9,203 |
Total revenues |  |  | 27,024 |  |  |  | 24,245 |
Cost of revenues |  |  | 3,729 |  |  |  | 3,487 |
Gross profit |  |  | 23,295 |  |  |  | 20,758 |
Operating expenses: |  |  |  |  |  |  |  |
Research and development, net |  |  | 19,837 |  |  |  | 17,609 |
Sales and marketing |  |  | 3,766 |  |  |  | 3,449 |
General and administrative |  |  | 4,660 |  |  |  | 3,933 |
Amortization of intangible assets |  |  | 117 |  |  |  | 149 |
Total operating expenses |  |  | 28,380 |  |  |  | 25,140 |
Operating loss |  |  | (5,085 | ) |  |  | (4,382 | )
Financial income, net |  |  | 1,877 |  |  |  | 2,100 |
Remeasurement of marketable equity securities |  |  | 64 |  |  |  | (54 | )
Loss before taxes on income |  |  | (3,144 | ) |  |  | (2,336 | )
Income tax expense |  |  | 1,315 |  |  |  | 991 |
Net loss |  | $ | (4,459 | ) |  | $ | (3,327 | )
Basic and diluted net loss per share |  | $ | (0.16 | ) |  | $ | (0.14 | )
Weighted-average shares used to compute net loss per share (in thousands): |  |  |  |  |  |  |  |
Basic and diluted |  |  | 27,678 |  |  |  | 23,764 |

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

6

Table of Contents

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)

U.S. dollars in thousands

|  | Three months ended |
|  | March 31, |
|  | 2026 |  |  | 2025 |
Net loss: |  | $ | (4,459 | ) |  | $ | (3,327 | )
Other comprehensive income (loss) before tax: |  |  |  |  |  |  |  |
Available-for-sale securities: |  |  |  |  |  |  |  |
Changes in unrealized gains (losses) |  |  | (707 | ) |  |  | 658 |
Reclassification adjustments for gains included in net loss |  |  | — |  |  |  | — |
Net change |  |  | (707 | ) |  |  | 658 |
Cash flow hedges: |  |  |  |  |  |  |  |
Changes in unrealized gains (losses) |  |  | 24 |  |  |  | (286 | )
Reclassification adjustments for gains included in net loss |  |  | (70 | ) |  |  | (80 | )
Net change |  |  | (46 | ) |  |  | (366 | )
Other comprehensive income (loss) before tax |  |  | (753 | ) |  |  | 292 |
Income tax expense (benefit) related to components of other comprehensive income (loss) |  |  | (14 | ) |  |  | 70 |
Other comprehensive income (loss), net of taxes |  |  | (739 | ) |  |  | 222 |
Comprehensive loss |  | $ | (5,198 | ) |  | $ | (3,105 | )

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

7

Table of Contents

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)

U.S. dollars in thousands, except share data

|  | Common stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Three months ended March 31, 2026 |  | Number of shares outstanding |  |  | Amount |  |  | Additional paid-in capital |  |  | Treasury stock |  |  | Accumulated other comprehensive income (loss) |  |  | Accumulated deficit |  |  | Total stockholders’ equity |
Balance as of January 1, 2026 |  |  | 27,510,739 |  |  | $ | 28 |  |  | $ | 337,966 |  |  | $ | (1,591 | ) |  | $ | 79 |  |  | $ | (24 | ) |  | $ | 336,458 |
Net loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (4,459 | ) |  |  | (4,459 | )
Other comprehensive loss, net |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (739 | ) |  |  | — |  |  |  | (739 | )
Equity-based compensation |  |  | — |  |  |  | — |  |  |  | 5,372 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 5,372 |
Issuance of common stock upon exercise of stock-based awards |  |  | 276,044 |  |  |  | — | (*) |  |  | 1,551 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,551 |
Issuance of treasury stock upon exercise of stock-based awards |  |  | 72,586 |  |  |  | — | (*) |  |  | (1,591 | ) |  |  | 1,591 |  |  |  | — |  |  |  | — |  |  |  | — |
Balance as of March 31, 2026 |  |  | 27,859,369 |  |  | $ | 28 |  |  | $ | 343,298 |  |  | $ | — |  |  | $ | (660 | ) |  | $ | (4,483 | ) |  | $ | 338,183 |

|  | Common stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Three months ended March 31, 2025 |  | Number of shares outstanding |  |  | Amount |  |  | Additional paid-in capital |  |  | Treasury stock |  |  | Accumulated other comprehensive income (loss) |  |  | Retained earnings |  |  | Total stockholders’ equity |
Balance as of January 1, 2025 |  |  | 23,626,865 |  |  | $ | 24 |  |  | $ | 259,891 |  |  | $ | (3,222 | ) |  | $ | (1,330 | ) |  | $ | 11,193 |  |  | $ | 266,556 |
Net loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (3,327 | ) |  |  | (3,327 | )
Other comprehensive income, net |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 222 |  |  |  | — |  |  |  | 222 |
Equity-based compensation |  |  | — |  |  |  | — |  |  |  | 4,323 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 4,323 |
Issuance of common stock upon exercise of stock-based awards |  |  | 158,965 |  |  |  | — | (*) |  |  | 1,358 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,358 |
Issuance of treasury stock upon exercise of stock-based awards |  |  | 129,390 |  |  |  | — | (*) |  |  | (2,715 | ) |  |  | 3,222 |  |  |  | — |  |  |  | (507 | ) |  |  | — |
Balance as of March 31, 2025 |  |  | 23,915,220 |  |  | $ | 24 |  |  | $ | 262,857 |  |  | $ | — |  |  | $ | (1,108 | ) |  | $ | 7,359 |  |  | $ | 269,132 |

(*) | Amount less than $1.

The accompanying notes are an integral part of the consolidated financial statements.

8

Table of Contents

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

U.S. dollars in thousands

|  | Three months ended March 31, |
|  | 2026 |  |  | 2025 |
Cash flows from operating activities: |  |  |  |  |  |  |  |
Net loss |  | $ | (4,459 | ) |  | $ | (3,327 | )
Adjustments required to reconcile net loss to net cash used in operating activities: |  |  |  |  |  |  |  |
Depreciation |  |  | 685 |  |  |  | 651 |
Amortization of intangible assets |  |  | 176 |  |  |  | 208 |
Equity-based compensation |  |  | 5,372 |  |  |  | 4,323 |
Accretion of discount on available-for-sale marketable securities |  |  | (104 | ) |  |  | (249 | )
Unrealized foreign exchange (gain) loss |  |  | 510 |  |  |  | (574 | )
Remeasurement of marketable equity securities |  |  | (64 | ) |  |  | 54 |
Changes in operating assets and liabilities: |  |  |  |  |  |  |  |
Trade receivables, net |  |  | 374 |  |  |  | (3,473 | )
Prepaid expenses and other assets |  |  | (5,847 | ) |  |  | (3,712 | )
Operating lease right-of-use assets |  |  | 296 |  |  |  | 530 |
Accrued interest on bank deposits |  |  | (35 | ) |  |  | (24 | )
Deferred tax, net |  |  | (3 | ) |  |  | 215 |
Trade payables |  |  | (295 | ) |  |  | 1,361 |
Deferred revenues |  |  | (528 | ) |  |  | (645 | )
Accrued expenses and other payables |  |  | (910 | ) |  |  | (1,113 | )
Accrued payroll and related benefits |  |  | (799 | ) |  |  | (842 | )
Operating lease liability |  |  | 705 |  |  |  | (850 | )
Accrued severance pay, net |  |  | 41 |  |  |  | 63 |
Net cash used in operating activities |  |  | (4,885 | ) |  |  | (7,404 | )
Cash flows from investing activities: |  |  |  |  |  |  |  |
Purchase of property and equipment |  |  | (2,315 | ) |  |  | (311 | )
Investment in bank deposits |  |  | (3,000 | ) |  |  | — |
Investment in available-for-sale marketable securities |  |  | (24,601 | ) |  |  | (29,117 | )
Proceeds from maturity of available-for-sale marketable securities |  |  | 14,110 |  |  |  | 35,660 |
Net cash provided by (used in) investing activities |  |  | (15,806 | ) |  |  | 6,232 |
Cash flows from financing activities: |  |  |  |  |  |  |  |
Proceeds from exercise of stock-based awards |  |  | 1,551 |  |  |  | 1,358 |
Net cash provided by financing activities |  |  | 1,551 |  |  |  | 1,358 |
Effect of exchange rate changes on cash and cash equivalents |  |  | (79 | ) |  |  | 130 |
Increase (decrease) in cash and cash equivalents |  |  | (19,219 | ) |  |  | 316 |
Cash and cash equivalents at the beginning of the period |  |  | 40,586 |  |  |  | 18,498 |
Cash and cash equivalents at the end of the period |  | $ | 21,367 |  |  | $ | 18,814 |
Supplemental information of cash flow activities: |  |  |  |  |  |  |  |
Cash paid during the period for: |  |  |  |  |  |  |  |
Income and withholding taxes |  | $ | 1,962 |  |  | $ | 1,703 |
Non-cash transactions: |  |  |  |  |  |  |  |
Property and equipment purchases incurred but unpaid at period end |  | $ | 326 |  |  | $ | 41 |
Right-of-use assets obtained in the exchange for operating lease liabilities |  | $ | 159 |  |  | $ | 87 |

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

9

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(in thousands, except share data)

NOTE 1: | BUSINESS

The financial information in this quarterly report includes the results of Ceva, Inc. and its subsidiaries (the “Company” or “Ceva”).

Ceva is the leader in silicon and software IP enabling Physical AI – the artificial intelligence embedded in billions of devices that connect, sense and infer data in the real world. Ceva views Physical AI as the natural evolution of Edge AI. While Edge AI refers to running AI workloads locally on devices rather than in the cloud, Physical AI extends this concept further: it unifies connectivity, sensing and inference layers into a single fabric that allows devices not only to process data at the edge, but also to interact intelligently with their physical environment and the cloud. Ceva believes it is uniquely positioned as the only company with leadership in innovative silicon and software IP solutions across all three layers. Ceva’s technologies power the connectivity, perception and intelligence in today’s most advanced smart edge products across consumer IoT, automotive, industrial and infrastructure, and mobile and PC markets.

Ceva is a trusted partner to many of the leading semiconductor and original equipment manufacturer (“OEM”) companies servicing not only Ceva’s largest target growth markets but also a wide variety of other applications, including smart-home, surveillance, robotics and medical. Ceva’s customers incorporate Ceva’s IP into application-specific integrated circuits and application-specific standard products that they manufacture, market and sell.

Ceva’s portfolio spans the three foundational layers of Physical AI:

| ● | Connectivity layer (wireless transport): Bluetooth, Wi-Fi, Ultra Wideband (“UWB”), cellular internet-of-things (“IoT”), and 5G Advanced IP platforms that form the backbone of ubiquitous, secure, and high-performance communication

| ● | Sensing layer (software and DSPs): Sensor fusion processors, RealSpace spatial audio, MotionEngine software, and general-purpose digital signal processors (“DSPs”) that transform raw sensor data into actionable intelligence

| ● | Inference layer (NPUs and AI DSPs): The NeuPro family of neural processing units (“NPUs”), from NeuPro-Nano for embedded AI to NeuPro-M for generative AI, supported by a unified toolchain and software stack for simple model deployment, and the SensPro family of AI DSPs for high-performance signal and AI workloads

Ceva licenses its portfolio of wireless communications and scalable AI IP to its customers, lowering barriers to entry and enabling them to bring new products to market faster, more reliably, efficiently and economically.

NOTE 2: | BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The interim condensed consolidated financial statements and accompanying notes have been prepared according to U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).

In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2026, are not necessarily indicative of the results that may be expected for the year ending December 31, 2026. For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.

The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2025, contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 27, 2026, have been applied consistently in these unaudited interim condensed consolidated financial statements.

10

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

Concentration of credit risk:

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, bank deposits, marketable securities, foreign exchange contracts and trade receivables. The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines relating to diversification and maturities to maintain safety and liquidity of the investments.

The majority of the Company’s cash and cash equivalents are invested in high grade certificates of deposits with major U.S., European and Israeli banks. Generally, cash and cash equivalents and bank deposits may be redeemed on demand and therefore minimal credit risk exists with respect to them. Nonetheless, deposits with these banks exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits or similar limits in foreign jurisdictions, to the extent such deposits are even insured in such foreign jurisdictions. Generally, these cash equivalents may be redeemed upon demand, and therefore management believes that they bear a lower risk. The short-term bank deposits are held in financial institutions that management believes are institutions with high credit standing and, accordingly, minimal credit risk from geographic or credit concentration. Furthermore, the Company holds an investment portfolio consisting principally of corporate bonds. For available-for-sale debt securities with unrealized loss positions, the Company does not intend to sell these securities and it is more likely than not that the Company will hold these securities until maturity or a recovery of the cost basis. No material credit losses for available-for-sale debt securities were recorded during the periods presented.

The Company’s trade receivables are geographically diverse, mainly in the Asia Pacific region, and also in the United States and Europe. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its customers. The Company makes estimates of expected credit losses based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers.

As of March 31, 2026, the allowance for credit losses amounted to $288.

The Company has no off-balance-sheet concentration of credit risk.

Recently Adopted Accounting Standards

In July 2025, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets (“ASU 2025-05”). This amendment introduces a practical expedient for the application of the current expected credit loss model to current accounts receivable and contract assets. ASU 2025-05 is effective for fiscal years beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The Company adopted this guidance on January 1, 2026 on a prospective basis. The Company has elected the practical expedient provided by ASU 2025-05. Under this expedient, the Company assumes that economic conditions as of the balance sheet date remain unchanged for the remaining life of all current accounts receivable and current contract assets arising from transactions under ASC 606. The adoption did not have a material impact on the consolidated financial statements.

Accounting Standards Recently Issued, Not Yet Adopted by the Company

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure of disaggregated information about certain expense captions presented in the Consolidated Statements of Operations as well as disclosure about selling expense. The guidance will be effective for the Company for annual periods beginning January 1, 2027 and interim periods beginning January 1, 2028, with early adoption permitted. It could be applied either prospectively or retrospectively. The Company is currently evaluating the impact on its financial statement disclosures.

In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The ASU simplifies the capitalization guidance by removing all references to prescriptive and sequential software development stages (referred to as “project stages”) throughout ASC 350-40. The ASU is effective for annual periods beginning after December 15, 2027, and interim periods within those fiscal years. Adoption of this ASU can be applied prospectively for reporting periods after its effective date; or follow a modified transition approach. The Company is currently evaluating the impact of this amendment on its consolidated financial statements and related disclosures.

11

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

In December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities. The update provides recognition, measurement, presentation, and disclosure requirements for government grants, including guidance for grants related to an asset and grants related to income. The amendments introduced two permitted approaches for asset-related grants: a deferred income approach or a cost accumulation approach. The guidance is effective for the Company beginning January 1, 2029, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements.

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. The ASU was updated to improve the navigability of the required interim disclosures within ASC No. 270 and to clarify when the guidance applies. This ASU is not intended to change the fundamental nature of interim reporting or expand or reduce current interim disclosure requirements. The amendments in this ASU are required to be adopted for interim reporting periods beginning after December 15, 2027, with early adoption permitted, and may be applied either through a prospective or retrospective approach. The Company is currently evaluating the effect of adopting the ASU on its condensed consolidated financial statement disclosures.

Government grants and tax credits

On March 31, 2026, the Israeli Knesset enacted Chapter 10, "Law for the Encouragement and Incentivization of Research and Development, 2026" (the “R&D Law”). The R&D Law introduces a refundable tax credit regime for qualifying research and development expenditures incurred in Israel, effective for tax years beginning January 1, 2026. Subject to certain conditions, eligible companies may apply the credit against Israeli income taxes or Israeli qualified domestic minimum top-up tax, or alternatively receive a government grant to the extent the credit is not utilized. Government grants and refundable tax credits, such as those provided under the recently enacted Israeli legislation, are recognized as a reduction to the related expense when there is reasonable assurance that the Company complies with required conditions and the incentive will be received. For the three months ended March 31, 2026, the Company recorded $203 of Israeli tax credits as a reduction of research and development expenses.

Use of Estimates

The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

12

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

NOTE 3: | REVENUE RECOGNITION

Under Accounting Standards Codification (“ASC”) No. 606, “Revenue from Contracts with Customers” (“ASC 606”), the Company recognizes revenue when or as it satisfies a performance obligation by transferring intellectual property (“IP”) licenses or services to the customer, either at a point in time or over time. The Company recognizes most of its revenues at a point in time upon delivery when the customer accepts control of the IP. The Company recognizes revenue over time on license customization and implementation services by using cost inputs to measure progress toward completion of its performance obligations. The Company considers the post-contract support services as a distinct performance obligation that is satisfied over time, and as such, revenue is recognized ratably over the service period.

Revenues that are derived from the sale of a licensee’s products that incorporate the Company’s IP are classified as royalty revenues. Royalty revenues are recognized during the quarter in which the sale of the product incorporating the Company’s IP occurs. Royalties are calculated either as a percentage of the revenues received by the Company’s licensees on sales of products incorporating the Company’s IP or on a per unit basis, as specified in the agreements with the licensees. Royalty revenues are recognized during the quarter in which the Company receives the actual sales data from its customers after the quarter ends and accounts for it as unbilled receivables. When the Company does not receive actual sales data from the customer prior to the finalization of its financial statements, royalty revenues are recognized based on the Company’s estimation of the customer’s sales during the quarter. This estimation process for the royalty revenue accrual is based on inputs and estimations received from the Company’s customers, as well as sales trends and various market factors. Adjustments to royalty revenues are made in subsequent periods to reflect updated estimates as soon as the final royalty reports are sent to the Company.

The following table includes estimated revenue expected to be recognized in future periods related to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. The estimated revenues do not include amounts of royalties or unexercised contract renewals:

|  | Remainder of 2026 |  |  | 2027 |  |  | 2028 and thereafter |
Licensing and related revenues |  | $ | 11,352 |  |  | $ | 2,161 |  |  | $ | 658 |

13

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

Disaggregation of revenue:

The following table provides information about disaggregated revenue by primary geographical, use cases for the Company's technology portfolio, and timing of revenue recognition:

|  | Three months ended March 31, 2026 (unaudited) |  |  | Three months ended March 31, 2025 (unaudited) |
|  | Licensing and related revenues |  |  | Royalties |  |  | Total |  |  | Licensing and related revenues |  |  | Royalties |  |  | Total |
Geography |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
United States |  | $ | 5,840 |  |  | $ | 1,610 |  |  | $ | 7,450 |  |  | $ | 2,415 |  |  | $ | 1,204 |  |  | $ | 3,619 |
Europe and Middle East |  |  | 318 |  |  |  | 661 |  |  |  | 979 |  |  |  | 506 |  |  |  | 978 |  |  |  | 1,484 |
Asia Pacific |  |  | 11,662 |  |  |  | 6,933 |  |  |  | 18,595 |  |  |  | 12,121 |  |  |  | 7,021 |  |  |  | 19,142 |
Total |  | $ | 17,820 |  |  | $ | 9,204 |  |  | $ | 27,024 |  |  | $ | 15,042 |  |  | $ | 9,203 |  |  | $ | 24,245 |
Use cases for the Company’s technology portfolio |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT) |  | $ | 12,924 |  |  | $ | 6,909 |  |  | $ | 19,833 |  |  | $ | 13,513 |  |  | $ | 6,932 |  |  | $ | 20,445 |
Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI) |  |  | 4,896 |  |  |  | 2,295 |  |  |  | 7,191 |  |  |  | 1,529 |  |  |  | 2,271 |  |  |  | 3,800 |
Total |  | $ | 17,820 |  |  | $ | 9,204 |  |  | $ | 27,024 |  |  | $ | 15,042 |  |  | $ | 9,203 |  |  | $ | 24,245 |
Timing of revenue recognition |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Products transferred at a point in time |  | $ | 14,679 |  |  | $ | 9,204 |  |  | $ | 23,883 |  |  | $ | 11,390 |  |  | $ | 9,203 |  |  | $ | 20,593 |
Products and services transferred over time |  |  | 3,141 |  |  |  | — |  |  |  | 3,141 |  |  |  | 3,652 |  |  |  | — |  |  |  | 3,652 |
Total |  | $ | 17,820 |  |  | $ | 9,204 |  |  | $ | 27,024 |  |  | $ | 15,042 |  |  | $ | 9,203 |  |  | $ | 24,245 |

14

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

Contract balances:

The following table provides information about trade receivables, unbilled receivables and contract liabilities from contracts with customers:

|  | March 31, 2026 |  |  | December 31, 2025 |
Currents assets (classified under “Trade receivables”): |  |  |  |  |  |  |  |
Trade receivables |  | $ | 17,737 |  |  | $ | 19,495 |
Unbilled receivables (associated with licensing and related revenues) |  |  | 21,975 |  |  |  | 16,545 |
Unbilled receivables (associated with royalties) |  |  | 9,160 |  |  |  | 13,315 |
Total current assets |  |  | 48,872 |  |  |  | 49,355 |
Long-term assets (classified under “Other long-term assets”): |  |  |  |  |  |  |  |
Unbilled receivables (associated with licensing and related revenues) |  |  | 2,579 |  |  |  | 1,176 |
Deferred revenues (short-term contract liabilities) |  |  | 2,968 |  |  |  | 3,496 |

The Company receives payments from customers based upon contractual payment schedules; trade receivables are recorded when the right to consideration becomes unconditional, and an invoice is issued to the customer. Unbilled receivables associated with licensing and other include amounts related to the Company’s contractual right to consideration for completed performance objectives not yet invoiced. Unbilled receivables associated with royalties are recorded as the Company recognizes revenues from royalties earned during the quarter, but not yet invoiced, either by actual sales data received from customers, or, when applicable, by the Company’s estimation. Contract liabilities (deferred revenue) include payments received in advance of performance under the contract and are realized with the associated revenue recognized under the contract.

During the three months ended March 31, 2026, the Company recognized $1,454 that was included in deferred revenues (short-term contract liability) balance at December 31, 2025.

Payment terms and conditions vary by contract type, although terms generally include a requirement of payment within 30 to 60 days.

Costs to obtain a contract:

As of March 31, 2026 and December 31, 2025, the Company had a remaining contract cost asset of $45 and $76, respectively, related to the incremental costs of obtaining the contract arising from sales commissions. During the three months ended March 31, 2026 and 2025, the Company recognized amortization of contract costs of $31 and $105, respectively. The Company recorded these costs within sales and marketing expenses on the Company’s interim condensed consolidated statements of loss.

15

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

NOTE 4: | MARKETABLE SECURITIES

The following is a summary of available-for-sale marketable securities:

|  | March 31, 2026 (Unaudited) |
|  | Amortized cost |  |  | Gross unrealized gains |  |  | Gross unrealized losses |  |  | Fair value |
Available-for-sale - matures within one year: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate bonds |  | $ | 111,257 |  |  | $ | 65 |  |  | $ | (297 | ) |  | $ | 111,025 |
Available-for-sale - matures after one year through four years: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate bonds |  |  | 78,595 |  |  |  | 82 |  |  |  | (512 | ) |  |  | 78,165 |
Total |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | $ | 189,852 |  |  | $ | 147 |  |  | $ | (809 | ) |  | $ | 189,190 |

|  | December 31, 2025 |
|  | Amortized cost |  |  | Gross unrealized gains |  |  | Gross unrealized losses |  |  | Fair value |
Available-for-sale - matures within one year: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate bonds |  | $ | 106,154 |  |  | $ | 157 |  |  | $ | (407 | ) |  | $ | 105,904 |
Available-for-sale - matures after one year through three years: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate bonds |  |  | 73,103 |  |  |  | 366 |  |  |  | (71 | ) |  |  | 73,398 |
Total |  | $ | 179,257 |  |  | $ | 523 |  |  | $ | (478 | ) |  | $ | 179,302 |

16

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of March 31, 2026 and December 31, 2025 and the length of time that those investments have been in a continuous loss position:

|  | Less than 12 months |  |  | 12 months or greater |
|  | Fair value |  |  | Gross unrealized loss |  |  | Fair value |  |  | Gross unrealized loss |
As of March 31, 2026 (unaudited) |  | $ | 99,907 |  |  | $ | (582 | ) |  | $ | 25,012 |  |  | $ | (227 | )
As of December 31, 2025 |  | $ | 65,252 |  |  | $ | (115 | ) |  | $ | 32,678 |  |  | $ | (363 | )

As of March 31, 2026, the allowance for credit losses was not material.

For the three months ended March 31, 2026 and 2025, the Company did not sell any available‑for‑sale marketable securities and therefore recognized no gains or losses from such sales during these periods.

NOTE 5: | FAIR VALUE MEASUREMENT

FASB ASC No. 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value. Fair value is an exit price, representing the amount that would be received for selling an asset or paid for the transfer of a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:

Level I | Unadjusted quoted prices in active markets that are accessible on the measurement date for identical, unrestricted assets or liabilities;
Level II | Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and
Level III | Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

17

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

The Company measures its marketable securities, investments in marketable equity securities and foreign currency derivative contracts at fair value. The carrying amount of cash, cash equivalents, short-term bank deposits, trade receivables, other accounts receivable, trade payables and other accounts payables approximate fair value due to the short-term maturity of these instruments. Investments in marketable equity securities are classified within Level I as the securities are traded in an active market. Marketable securities and foreign currency derivative contracts are classified within Level II as the valuation inputs are based on quoted prices and market observable data of similar instruments.

The table below sets forth the Company’s assets and liabilities measured at fair value by level within the fair value hierarchy. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

Description |  | March 31, 2026 (unaudited) |  |  | Level I (unaudited) |  |  | Level II (unaudited) |  |  | Level III (unaudited) |
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Marketable securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate bonds |  | $ | 189,190 |  |  | $ | — |  |  | $ | 189,190 |  |  | $ | — |
Investments in marketable equity securities |  | $ | 119 |  |  | $ | 119 |  |  | $ | — |  |  | $ | — |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign exchange contracts |  | $ | 25 |  |  | $ | — |  |  | $ | 25 |  |  | $ | — |

Description |  | December 31, 2025 |  |  | Level I |  |  | Level II |  |  | Level III |
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Marketable securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate bonds |  | $ | 179,302 |  |  | $ | — |  |  | $ | 179,302 |  |  | $ | — |
Foreign exchange contracts |  | $ | 21 |  |  | $ | — |  |  | $ | 21 |  |  | $ | — |
Investments in marketable equity securities |  | $ | 55 |  |  | $ | 55 |  |  | $ | — |  |  | $ | — |

NOTE 6: | GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER DATA

The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is regularly evaluated by the Company’s chief operating decision maker (“CODM”), which is the Company’s chief executive officer, in deciding how to allocate resources and assess performance. The Company’s CODM evaluates the Company’s financial information and resources and assesses the performance of these resources on a consolidated basis. There is no expense or asset information that are supplemental to those disclosed in these interim condensed consolidated financial statements that are regularly provided to the CODM. The allocation of resources and assessment of performance of the operating segment is based on consolidated net income as shown in our interim condensed consolidated statements of loss. The CODM considers net income in the annual forecasting process and reviews actual results when making decisions about allocating resources. Since the Company operates as one operating segment, financial segment information, including profit or loss and asset information, can be found in these interim condensed consolidated financial statements.

| a. | Summary information about geographic areas:

The following is a summary of revenues and long-lived assets (including ROU assets) within geographic areas:

|  | Three months ended March 31, |
|  | 2026 (unaudited) |  |  | 2025 (unaudited) |
Revenues based on customer location: |  |  |  |  |  |  |  |
United States |  | $ | 7,450 |  |  | $ | 3,619 |
Europe and Middle East |  |  | 979 |  |  |  | 1,484 |
Asia Pacific (1) |  |  | 18,595 |  |  |  | 19,142 |
|  | $ | 27,024 |  |  | $ | 24,245 |
(1) China |  | $ | 15,264 |  |  | $ | 16,066 |

18

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

|  | March 31, 2026 (unaudited) |  |  | December 31, 2025 |
Long-lived assets by geographic region: |  |  |  |  |  |  |  |
Israel |  | $ | 21,355 |  |  | $ | 19,330 |
France |  |  | 1,619 |  |  |  | 1,682 |
United States |  |  | 939 |  |  |  | 1,064 |
Greece |  |  | 1,216 |  |  |  | 1,255 |
Other |  |  | 1,071 |  |  |  | 1,209 |
|  | $ | 26,200 |  |  | $ | 24,540 |

| b. | Major customer data as a percentage of total revenues:

The following table sets forth the customers that represented 10% or more of the Company’s total revenues in each of the periods set forth below:

|  | Three months ended March 31, |
|  | 2026 (unaudited) |  |  | 2025 (unaudited) |
Customer A |  |  | * | ) |  |  | 24 | %
Customer B |  |  | 14 | % |  |  | * | )
Customer C |  |  | 10 | % |  |  | * | )

*) Less than 10%

| c. | Major customer data as a percentage of total trade receivable:

The following table sets forth the customers that represented 10% or more of the Company’s total trade receivable in each of the periods set forth below:

|  | March 31, 2026 (unaudited) |  |  | December 31, 2025 |
Customer A |  |  | 19 | % |  |  | 22 | %

19

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

NOTE 7: | FINANCIAL INCOME, NET

|  | Three months ended March 31, |
|  | 2026 (unaudited) |  |  | 2025 (unaudited) |
Interest income |  | $ | 1,967 |  |  | $ | 1,251 |
Amortization of discount on available-for-sale marketable securities, net |  |  | 104 |  |  |  | 249 |
Foreign exchange gain (loss), net |  |  | (194 | ) |  |  | 600 |
Total |  | $ | 1,877 |  |  | $ | 2,100 |

NOTE 8: | NET LOSS PER SHARE OF COMMON STOCK

Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period. Diluted net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period, plus dilutive potential shares of common stock considered outstanding during the period, in accordance with FASB ASC No. 260, “Earnings Per Share.”

|  | Three months ended March 31, |
|  | 2026 (unaudited) |  |  | 2025 (unaudited) |
Numerator: |  |  |  |  |  |  |  |
Net loss |  | $ | (4,459 | ) |  | $ | (3,327 | )
Denominator (in thousands): |  |  |  |  |  |  |  |
Basic and diluted weighted average common stock outstanding |  |  | 27,678 |  |  |  | 23,764 |
Basic and diluted net loss per share |  | $ | (0.16 | ) |  | $ | (0.14 | )

The total number of shares related to outstanding equity-based awards was 2,116,283 and 1,843,440 for the three months ended March 31, 2026 and 2025, respectively, and in each case was excluded from the calculation of diluted net loss per share.

NOTE 9: | COMMON STOCK AND STOCK-BASED COMPENSATION PLANS

The Company grants stock options and restricted stock units (“RSUs”) to employees and non‑employee directors of the Company and its subsidiaries under the Company’s equity plans and provides the right to purchase common stock pursuant to the Company’s 2002 employee stock purchase plan (the “ESPP”) to employees of the Company and its subsidiaries.

20

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

The options granted under the Company’s stock incentive plans have been granted at the fair market value of the Company’s common stock on the grant date. Options granted to employees under stock incentive plans generally vest at a rate of 25% of the shares underlying the option after one year and the remaining shares vest in equal portions over the following 36 months, such that all shares are vested after four years. Options granted to non‑employee directors vest 25% of the shares underlying the option on each anniversary of the option grant date. A summary of the Company’s stock option activities and related information for the three months ended March 31, 2026, are as follows:

|  | Number of options |  |  | Weighted average exercise price |  |  | Weighted average remaining contractual term |  |  | Aggregate intrinsic value |
Outstanding as of December 31, 2025 |  |  | 57,025 |  |  | $ | 23.87 |  |  |  | 2.8 |  |  | $ | 20 |
Granted |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Exercised |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Forfeited or expired |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Outstanding as of March 31, 2026 (unaudited) |  |  | 57,025 |  |  | $ | 23.87 |  |  |  | 2.6 |  |  | $ | — |
Exercisable as of March 31, 2026 (unaudited) |  |  | 44,403 |  |  | $ | 24.77 |  |  |  | 1.9 |  |  | $ | — |

As of March 31, 2026, there was $133 of unrecognized compensation expense related to unvested stock options. This amount is expected to be recognized over a weighted-average period of 1.4 years.

An RSU award is an agreement to issue shares of the Company’s common stock at the time the award or a portion thereof vests. RSUs granted to employees generally vest in three equal annual installments starting on the first anniversary of the grant date. RSUs granted to non-employee directors are awarded following a director’s election or re-election to the Board at the Company’s annual meeting, and fully vest on the first-year anniversary of the grant date.

On February 11, 2026, the Compensation Committee of the Board (the “Committee”) granted 124,553 performance-based stock units (“PSUs”), effective as of February 19, 2026, to its executive officers pursuant to the Company’s 2011 Stock Incentive Plan. The maximum number of PSUs that may be earned based on performance achievement is 234,617. The PSUs vest based on the achievement of continued service, performance conditions and market conditions over a one‑year performance period ending December 31, 2026, such that (i) 50% of the award is subject to continued service and the achievement of financial performance targets based on license and related revenues, (ii) 25% of the award is subject to continued service and a total shareholder return (“TSR”) target whereby the Company’s TSR for 2026 must exceed the TSR of the S&P Semiconductors Select Industry Index, and (iii) 25% of the award is subject to continued service and a TSR target whereby the Company’s TSR for 2026 must exceed the TSR of the Russell 3000 Index. As of March 31, 2026, the achievement of the performance conditions was deemed probable.

21

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

Subject to achievement of the thresholds the above performance goals for 2026, the PSUs vest 33.4% on February 19, 2027, 33.3% on February 19, 2028, and 33.3% on February 19, 2029.

The grant‑date fair value of the TSR‑based PSUs was estimated using a Monte Carlo simulation model, which incorporates assumptions regarding stock price volatility, risk‑free interest rates, and expected dividends. The grant‑date fair value of the financial‑metric PSUs was based on the Company’s stock price on the grant date.

A summary of the Company’s RSU and PSU activities and related information for the three months ended March 31, 2026, are as follows:

|  | Number of RSUs and PSUs |  |  | Weighted Average Grant- Date Fair Value |
Unvested as of December 31, 2025 |  |  | 1,826,127 |  |  | $ | 23.00 |
Granted |  |  | 652,422 |  |  |  | 14.70 |
Vested |  |  | (261,155 | ) |  |  | 26.86 |
Forfeited or expired |  |  | (158,135 | ) |  |  | 29.36 |
Unvested as of March 31, 2026 (unaudited) |  |  | 2,059,259 |  |  | $ | 21.26 |

As of March 31, 2026, there was $29,772 of unrecognized compensation expense related to unvested RSUs and PSUs. This amount is expected to be recognized over a weighted-average period of 1.5 years.

The following table shows the total equity-based compensation expense included in the interim condensed consolidated statements of loss:

|  | Three months ended March 31, |
|  | 2026 (unaudited) |  |  | 2025 (unaudited) |
Cost of revenue |  | $ | 182 |  |  | $ | 159 |
Research and development, net |  |  | 2,863 |  |  |  | 2,466 |
Sales and marketing |  |  | 717 |  |  |  | 566 |
General and administrative |  |  | 1,610 |  |  |  | 1,132 |
Total equity-based compensation expense |  | $ | 5,372 |  |  | $ | 4,323 |

22

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

The fair value for rights to purchase shares of common stock under the Company’s employee stock purchase plan was estimated on the date of grant using the following assumptions:

|  | Three months ended March 31 |
|  | 2026 (unaudited) |  | 2025 (unaudited) |
Expected dividend yield |  | 0% |  | 0% |
Expected volatility |  | 55% | - | 64% |  | 41% | - | 48% |
Risk-free interest rate |  | 3.4% | - | 3.6% |  | 4.2% | - | 4.4% |
Contractual term of up to (months) |  | 6 | - | 24 |  | 6 | - | 24 |

During the first quarter of 2026, the Company's employees purchased 87,475 shares of its common stock under the ESPP. The shares were purchased at a weighted-average purchase price of $17.73 per share, with proceeds of $1,551. During the first quarter of 2025, the Company's employees purchased 70,207 shares of its common stock under the ESPP. The shares were purchased at a weighted-average purchase price of $19.34 per share, with proceeds of $1,358.

NOTE 10: | DERIVATIVES AND HEDGING ACTIVITIES

The Company follows the requirements of FASB ASC No. 815,” Derivatives and Hedging” which requires companies to recognize all of their derivative instruments as either assets or liabilities in the statement of financial position at fair value. The accounting for changes in fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging transaction and further, on the type of hedging transaction. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. Due to the Company’s global operations, it is exposed to foreign currency exchange rate fluctuations in the normal course of its business. The Company’s treasury policy allows it to offset the risks associated with the effects of certain foreign currency exposures through the purchase of foreign exchange forward or option contracts (“Hedging Contracts”). The policy, however, prohibits the Company from speculating on such Hedging Contracts for profit. To protect against the increase in value of forecasted foreign currency cash flow resulting mainly from salaries paid in currencies other than the U.S. dollar during the year, the Company instituted a foreign currency cash flow hedging program. The Company hedges portions of the anticipated payroll of its non-U.S. employees denominated in the currencies other than the U.S. dollar for a period of one to twelve months with Hedging Contracts. Accordingly, when the dollar strengthens against the foreign currencies, the decline in present value of future foreign currency expenses is offset by losses in the fair value of the Hedging Contracts. Conversely, when the dollar weakens, the increase in the present value of future foreign currency expenses is offset by gains in the fair value of the Hedging Contracts. These Hedging Contracts are designated as cash flow hedges.

For derivative instruments that are designated and qualify as a cash flow hedge (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. As of March 31, 2026 and December 31, 2025, the notional principal amount of the Hedging Contracts to sell U.S. dollars held by the Company was $8,150 and $2,625, respectively.

Other derivative instruments that are not designated as hedging instruments consist of forward contracts that the Company uses to hedge monetary assets denominated in currencies other than the U.S. dollar. Gains and losses on these contracts as well as related costs are included in financial income, net, along with the gains and losses of the related hedged item. There were no open other derivative instruments as of March 31, 2026 and December 31, 2025.

The fair value of the Company’s outstanding derivative instruments is as follows:

|  | March 31, 2026 (unaudited) |  |  | December 31, 2025 |
Derivative assets: |  |  |  |  |  |  |  |
Derivatives designated as cash flow hedging instruments: |  |  |  |  |  |  |  |
Foreign exchange forward contracts |  | $ | — |  |  | $ | 21 |
Total |  | $ | — |  |  | $ | 21 |
Derivative liabilities: |  |  |  |  |  |  |  |
Derivatives designated as cash flow hedging instruments: |  |  |  |  |  |  |  |
Foreign exchange forward contracts |  | $ | 25 |  |  | $ | — |
Total |  | $ | 25 |  |  | $ | — |

23

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

The increase (decrease) in unrealized gains (losses) recognized in “accumulated other comprehensive income (loss)” on derivatives, before tax effect, is as follows:

|  | Three months ended March 31, |
|  | 2026 (unaudited) |  |  | 2025 (unaudited) |
Derivatives designated as cash flow hedging instruments: |  |  |  |  |  |  |  |
Foreign exchange option contracts |  | $ | — |  |  | $ | (96 | )
Foreign exchange forward contracts |  |  | 24 |  |  |  | (190 | )
|  | $ | 24 |  |  | $ | (286 | )

The net gains reclassified from “accumulated other comprehensive income (loss)” into income are as follows:

|  | Three months ended March 31, |
|  | 2026 (unaudited) |  |  | 2025 (unaudited) |
Derivatives designated as cash flow hedging instruments: |  |  |  |  |  |  |  |
Foreign exchange option contracts |  | $ | — |  |  | $ | — |
Foreign exchange forward contracts |  |  | (70 | ) |  |  | (80 | )
|  | $ | (70 | ) |  | $ | (80 | )

The Company recorded in cost of revenues and operating expenses a net gain of $70 during the three months ended March 31, 2026, and a net gain of $80 during the comparable period of 2025, related to its Hedging Contracts.

NOTE 11: | ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The following table summarizes the changes in accumulated balances of other comprehensive income (loss), net of taxes:

|  | Three months ended March 31, 2026 (unaudited) |  |  | Three months ended March 31, 2025 (unaudited) |
|  | Unrealized gains (losses) on available- for-sale marketable securities |  |  | Unrealized gains (losses) on cash flow hedges |  |  | Total |  |  | Unrealized gains (losses) on available- for-sale marketable securities |  |  | Unrealized gains (losses) on cash flow hedges |  |  | Total |
Beginning balance |  | $ | 58 |  |  | $ | 21 |  |  | $ | 79 |  |  | $ | (1,330 | ) |  | $ | — |  |  | $ | (1,330 | )
Other comprehensive income (loss) before reclassifications |  |  | (693 | ) |  |  | 24 |  |  |  | (669 | ) |  |  | 588 |  |  |  | (286 | ) |  |  | 302 |
Amounts reclassified from accumulated other comprehensive income (loss) |  |  | — |  |  |  | (70 | ) |  |  | (70 | ) |  |  | — |  |  |  | (80 | ) |  |  | (80 | )
Net current period other comprehensive income (loss) |  |  | (693 | ) |  |  | (46 | ) |  |  | (739 | ) |  |  | 588 |  |  |  | (366 | ) |  |  | 222 |
Ending balance |  | $ | (635 | ) |  | $ | (25 | ) |  | $ | (660 | ) |  | $ | (742 | ) |  | $ | (366 | ) |  | $ | (1,108 | )

24

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

The following table provides details about reclassifications out of accumulated other comprehensive income (loss):

Details about Accumulated Other Comprehensive Income (Loss) Components |  | Amount Reclassified from Accumulated Other Comprehensive Income (Loss) |  | Affected Line Item in the Statements of Income (Loss)
|  | Three months ended March 31, |  |
|  | 2026 (unaudited) |  |  | 2025 (unaudited) |  |
Unrealized gains on cash flow hedges |  | $ | 1 |  |  | $ | 2 |  | Cost of revenues
|  |  | 59 |  |  |  | 67 |  | Research and development
|  |  | 2 |  |  |  | 3 |  | Sales and marketing
|  |  | 8 |  |  |  | 8 |  | General and administrative
|  |  | 70 |  |  |  | 80 |  | Total, before income taxes
|  |  | — |  |  |  | — |  | Income tax expense
|  | $ | 70 |  |  | $ | 80 |  | Total, net of income taxes

NOTE 12: | SHARE REPURCHASE PROGRAM

The Company did not repurchase any shares of common stock during the first quarter of both 2026 and 2025. As of March 31, 2026, 684,486 shares of common stock remained available for repurchase pursuant to the Company’s share repurchase program.

The repurchases of common stock are accounted for as treasury stock, and result in a reduction of stockholders’ equity. When treasury shares are reissued, the Company accounts for the reissuance in accordance with FASB ASC No. 505-30, “Treasury Stock” and charges the excess of the repurchase cost over issuance price using the weighted average method to retained earnings. The purchase cost is calculated based on the specific identification method. In the case where the repurchase cost over issuance price using the weighted average method is lower than the issuance price, the Company credits the difference to additional paid-in capital.

25

Table of Contents

Item 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion together with the unaudited financial statements and related notes appearing elsewhere in this Quarterly Report. This discussion contains forward-looking statements that involve risks and uncertainties. Any or all of our forward-looking statements in this Quarterly Report may turn out to be wrong. These forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Factors which could cause actual results to differ materially include those set forth in Part II—Item 1A—“Risk Factors” in this Quarterly Report and Part I—Item 1A—“Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 as well as those discussed elsewhere in this Quarterly Report. See “Forward-Looking Statements.”

The financial information presented in this Quarterly Report includes the results of Ceva, Inc. and its subsidiaries.

BUSINESS OVERVIEW

We enable Physical AI, the artificial intelligence embedded in billions of devices that connect, sense and infer data in the real world. We view Physical AI as the natural evolution of Edge AI. While Edge AI refers to running AI workloads locally on devices rather than in the cloud, Physical AI extends this concept further: it unifies connectivity, sensing and inference layers into a single fabric that allows devices not only to process data at the edge, but also to interact intelligently with their physical environment and the cloud. We believe Ceva is uniquely positioned as the only company with leadership in innovative silicon and software IP solutions across all three layers – connect, sense and infer.

In the first quarter of 2026, we continued to execute on our Physical AI strategy, generating revenues of $27.0 million, up 11% year-over-year, including licensing and related revenues of $17.8 million, our strongest licensing quarter in three years, reflecting strong customer engagement and pipeline momentum.

According to IPnest, we commanded 68% of the wireless connectivity IP market in 2024. Since 2003, more than 20 billion devices have shipped with Ceva IP, including approximately 2.1 billion in 2025. Our technologies power the connectivity, perception and intelligence in today’s most advanced smart edge products across consumer IoT, automotive, industrial and infrastructure, and mobile and PC markets. Based on market research, we believe these sectors will represent a $170 billion total addressable market for Physical AI and Edge AI by 2030.

Our portfolio spans:

| ● | Connectivity layer (wireless transport): Bluetooth, Wi‑Fi, Ultra‑Wideband (UWB), cellular internet-of-things (IoT), and 5G‑Advanced IP platforms that form the backbone of ubiquitous, secure, and high‑performance communication.

| ● | Sensing layer (software and DSPs): Sensor fusion processors, RealSpace spatial audio, MotionEngine software, and general‑purpose digital signal processors (DSPs) that transform raw sensor data into actionable intelligence.

| ● | Inference layer (NPUs and AI DSPs): The NeuPro family of neural processing units (NPUs), from NeuPro‑Nano for embedded AI to NeuPro‑M for generative AI, supported by a unified toolchain and software stack for simple model deployment, and the SensPro family of AI DSPs for high‑performance signal and AI workloads.

Together, these layers make Ceva, with our unified AI fabric, an essential enabler of Physical AI that breaks down barriers to entry and accelerates time‑to‑market for our customers. We are increasingly delivering more integrated, system-level solutions, enabling higher value per design, deeper customer engagement and greater long-term royalty potential.

For more than three decades, we have been a trusted partner to hundreds of leading semiconductor and original equipment manufacturer (OEM) companies, serving not only our largest target growth markets but also a wide variety of other applications, including smart home, surveillance, robotics and medical. Our transformative semiconductor IP and embedded software offerings are incorporated by customers into application-specific integrated circuits (ASICs) and application-specific standard products (ASSPs) to enable power‑efficient, intelligent, secure and connected devices that connect, sense and infer – the three critical pillars of the rapidly evolving era of AI‑enabled smart edge technology.

We license our portfolio of wireless communications and scalable Edge AI IP to our customers, breaking down barriers to entry and enabling them to bring new cutting-edge products to market faster, more reliably, efficiently and economically.

26

Table of Contents

We believe our portfolio of technologies comprised of connectivity, sensing and inference – the three foundational layers of Physical AI – positions Ceva at the center of the most important megatrends shaping the semiconductor industry, including 5G expansion, generative and embedded AI, industrial automation and vehicle electrification. Demand across these areas continues to drive strong interest in our IP portfolio, both in established markets and in new, emerging use cases.

In the first quarter of 2026, we signed 14 IP licensing agreements that underscore our momentum across connect, sense and infer. These included multiple multi-technology engagements, reflecting increasing customer adoption of more integrated solutions. In connectivity, we secured our first licensing agreement for a full Bluetooth 7 integrated solution, including modem, software and RF, with a leading U.S.-based analog semiconductor company, marking a key milestone in our strategy to deliver system-level wireless platforms. We also signed Wi-Fi 7 and Wi-Fi 6/Bluetooth combo engagements, along with additional Bluetooth and Wi-Fi agreements across consumer and industrial markets. In cellular, we introduced our PentaG-NTN 5G Advanced modem platform, extending our cellular portfolio into satellite communications, and expanded a customer engagement into a more integrated baseband processing solution, increasing both the scope and long-term value of the relationship. In AI, we signed multiple licensing agreements across automotive and surveillance applications, reflecting growing demand for embedded AI and edge inference solutions.

AI-related licensing represented more than 20% of total licensing and related revenues in the quarter, highlighting the accelerating adoption of edge AI across multiple end markets.

We believe the following key elements represent significant growth drivers for Ceva as the leader in silicon and software IP enabling Physical AI, spanning the three foundational layers of connectivity, sensing and inference:

| ● | Connectivity layer – Foundation for billions of devices: Our broad Bluetooth, Wi‑Fi, UWB, and cellular IoT IP platforms address the high‑volume IoT, industrial, consumer, and smart home markets. ABI Research projects more than 16.5 billion devices annually by 2029. With leadership in Wi‑Fi 6 and Wi‑Fi 7 IP, and record Wi‑Fi 6 shipments in 2025, we believe we are positioned to capture higher royalty revenues as customers transition to newer standards.

| ● | Connectivity layer – 5G everywhere: Our PentaG2 platform and DSPs for 5G mobile broadband, 5G RedCap and 5G Advanced, including our PentaG-NTN solution for satellite communications, provide one of the industry’s most comprehensive baseband IP solutions, enabling fixed wireless access, satellite communications, robotics, automotive and industrial applications.

| ● | Connectivity layer – Infrastructure intelligence: Our PentaG RAN platform, including the Ceva‑XC22 multi‑thread DSP, extends our leadership into 5G RAN and 5G Advanced for data centers and infrastructure, enabling scalable, customizable solutions for next‑generation networks.

| ● | Sensing layer – Consumer audio and spatial intelligence: High‑volume consumer audio markets such as TWS earbuds, AR/VR headsets, and wearables represent incremental growth opportunities for our Bluetooth, Audio AI DSPs, NPUs and RealSpace Spatial Audio & Head Tracking software. Recent design wins with Nothing and other consumer brands highlight growing adoption.

| ● | Sensing layer – Software intelligence at scale: Our MotionEngine software, already shipped in more than 500 million devices, enhances MEMS‑based inertial and environmental sensors across robotics, smartphones, laptops, TWS earbuds, and more. Combined with our SensPro DSPs and NeuPro NPUs, we believe this positions Ceva as a one‑stop shop for sensor processing and AI‑driven user experiences.

| ● | Inference layer – Generative and classic AI at the edge: Our NeuPro‑M AI NPU family delivers efficient, high‑performance architectures for generative and classic AI across devices from gateways and notebooks to AR/VR and smartphones. Recent agreements include Microchip’s portfolio license win for our NeuPro-M and NeuPro-Nano family of NPUs.

| ● | Inference layer – Embedded AI and TinyML: Our NeuPro‑Nano NPUs bring cost‑ and power‑efficient AI to microcontrollers and systems-on-chips (SoCs), enabling artificial IoT (AIoT) devices for sound, vision, vibration, and health monitoring. ABI Research projects that by 2030, over 50% of TinyML shipments will be powered by dedicated embedded AI hardware such as NeuPro‑Nano.

27

Table of Contents

| ● | Inference layer – AI DSPs for perception and sensor intelligence: Our SensPro2 AI DSP family addresses demand for efficient, high‑performance AI signal processing across sensor‑rich applications, from smartphones and drones to automotive ADAS and industrial IoT.

As a result of our focus on silicon and software IP solutions spanning the connectivity, sensing and inference layers of Physical AI, we believe Ceva is well positioned for sustained, long‑term growth in both shipments and royalty revenues. Our diversified royalty streams reflect a broad range of advanced semiconductor packages (ASPs) – from high‑volume Bluetooth and Wi‑Fi connectivity platforms that power billions of consumer devices to higher‑value inference engines and AI DSPs such as NeuPro and SensPro, as well as infrastructure‑class platforms like PentaG-RAN. We believe this mix provides both scale and resilience, enabling us to capture growth across consumer, automotive, industrial and infrastructure markets while reinforcing our role as the enabler of Physical AI.

CURRENT TRENDS

We believe the long-term trend of digital transformation is evolving into a new era defined by Physical AI – the next phase of Edge AI – where intelligence is embedded directly into the devices that connect, sense and interact with the real world. Our ubiquitous IP portfolio and collaborative licensing model position us to capture secular growth across consumer IoT, automotive, industrial and infrastructure, and mobile and PC markets.

Our customers are increasingly adopting our roadmap as they seek to integrate connectivity, sensing and intelligence into their devices. The first quarter of 2026 provided further evidence of this trend, with 14 licensing agreements, including multiple multi-technology engagements across connectivity and AI, reinforcing demand for our connect, sense and infer portfolio.

On royalties, we continue to see encouraging momentum across our diversified smart edge markets, with growth in consumer IoT, industrial and AI-driven applications. In the first quarter of 2026, Ceva-powered device shipments reached 458 million units, up 9% year-over-year. Wi-Fi shipments reached a record level, driven by strong adoption of Wi-Fi 6 across a broad range of devices, while cellular IoT shipments grew 38% year-over-year, reflecting continued expansion across connected applications.

We are also seeing early contributions from AI-driven royalties, highlighted by our first mass-volume automotive AI deployment and a ramping AI SoC for surveillance, marking the initial phase of what we expect to become a meaningful long-term growth driver.

In the first quarter, royalty performance was impacted by typical seasonal softness in mobile, combined with near-term effects from memory availability constraints and channel inventory in lower-tier smartphone segments. We view these dynamics as largely timing-related and expect improvement as the year progresses.

In addition, we expect to complement our strong presence in the Asia-Pacific region by further expanding our customer base and revenues in Europe and the U.S., as reflected in our increasingly diversified geographic revenue mix in recent years. This balance strengthens our resilience and underscores Ceva’s role as a leader in silicon and software IP enabling Physical AI across global markets.

However, the global economy continued to be impacted by macroeconomic conditions, including a volatile interest rate environment, foreign currency exchange rate fluctuations, ongoing inflation, world conflicts and uncertainty, like the Middle East conflict and higher fuel and oil prices, as well as changes in legislation and regulations, including enacted and proposed tariffs and other trade policies, which introduced additional uncertainty. In periods of perceived or actual unfavorable economic conditions, our customers or potential customers may delay or re-evaluate their decisions to initiate projects, which could result in a delay or cessation of engagements with us and lower licensing revenues. In addition, weaker consumer demand may result in lower royalty revenues as our customers ship fewer units, and supply chain dynamics and component pricing may also impact end-market demand.

Given these evolving dynamics, as well as our lower-than-anticipated revenues for the first quarter of 2025, in May 2025 we adopted a more cautious outlook and lowered our revenue guidance for fiscal year 2025 from high-single-digit growth to low-single-digit growth over 2024 annual revenues. We finished fiscal year 2025 with total revenues of $109.6 million, which was in line with this more cautious approach. Licensing was a relative strength during the year, while royalty revenues were affected by end-market consumer demand dynamics, including the impact of memory pricing and supply constraints on the low-end smartphone market. We anticipate that these factors may continue to impact consumer demand and our royalty revenue growth expectations into 2026. With that said, we’ve increased our overall 2026 revenue growth guidance to be at the higher end of 8%-12% year-over-year.

Instability in the Middle East

Our operations in Israel remain largely unaffected by the war between Israel and Hamas that began on October 7, 2023 and escalated to conflicts with Lebanon, Hezbollah and Iran. Most recently, in February 2026, the United States and Israel launched joint combat operations in Iran to which Iran and Hezbollah responded with ballistic missile and drone attacks on Israel as well as other countries and U.S. military bases in the region. While temporary ceasefires between the United States, Israel and Iran, and between Israel and Hezbollah, were reached in April 2026 and remain in effect as of the date hereof, there can be no assurance that the temporary ceasefire agreements will be upheld or that permanent ceasefires will be reached, and the situation in Israel and the region remains highly volatile. Despite the evolving geopolitical situation, we continue to drive our business and support our customers globally. However, a portion of our employees in Israel have been or are called to active reserve duty, and additional employees may be called in the future, if needed. We have executed our business continuity plan with respect to those employees. It is possible that some of our operations in the region may be disrupted if this continues for a significant period of time or if the situation further deteriorates. The intensity and duration of these conflicts, as well as their economic implications for the Company and Israel’s economy, remain difficult to predict. For more information, please refer to the risk factor titled “Our operations in Israel may be adversely affected by instability in the Middle East region” in Part I—Item 1A—“Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025.

28

Table of Contents

RESULTS OF OPERATIONS

Total Revenues

Total revenues were $27.0 million for the first quarter of 2026, representing an increase of 11% as compared to the corresponding period in 2025. The increase in total revenues for the first quarter of 2026 was due to higher licensing and related revenues, as further described below.

Our five largest customers accounted for 44% of our total revenues for the first quarter of 2026, as compared to 56% for the comparable period in 2025. Two customers accounted for 24% of our total revenues for the first quarter of 2026, as compared to one customer that accounted for 24% of our total revenues for the first quarter of 2025. Generally, the identity of our customers representing 10% or more of our total revenues varies from period to period, especially with respect to our IP licensing customers as we generate licensing revenues generally from new customers on a quarterly basis. With respect to our royalty revenues, two royalty paying customers represented 10% or more of our total royalty revenues for the first quarter of 2026 and collectively represented 22% of our total royalty revenues for the first quarter of 2026. Two royalty paying customers represented 10% or more of our total royalty revenues for the first quarter of 2025 and collectively represented 30% of our total royalty revenues for the first quarter of 2025. We expect that a significant portion of our future revenues will continue to be generated by a limited number of customers. The concentration of our customers is explainable, in part, by consolidation in the semiconductor industry.

The following table sets forth use cases for the Ceva technology portfolio as percentages of our total revenues for each of the periods set forth below:

|  | First Quarter 2026 |  |  | First Quarter 2025 |
Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT) |  |  | 73 | % |  |  | 84 | %
Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI) |  |  | 27 | % |  |  | 16 | %

Licensing and Related Revenues

Licensing and related revenues was $17.8 million for the first quarter of 2026, representing an increase of 18% as compared to the corresponding period in 2025. In licensing, our expanding portfolio, combined with our strategy to deliver more integrated, system-level solutions, is enabling us to increase our value per customer. This quarter, we secured our first licensing win for a complete Bluetooth High Data Throughput, or HDT, solution, a foundational capability for the upcoming Bluetooth 7 standard. We licensed this full solution, including modem, software and RF, to a leading U.S.-based analog semiconductor company. We also signed multiple AI‑related licensing agreements, including an NPU deal for surveillance and an AI tools engagement with a global automotive OEM. AI represented more than 20% of our licensing and related revenues in the quarter. Our AI licensing pipeline remains strong, with multiple evaluations and advanced negotiations underway across a broad range of end markets.

During the quarter, 14 IP licensing agreements were signed, including two with OEMs. We secured a Wi-Fi 7 design targeting consumer IoT, a Wi-Fi 6 / Bluetooth combo engagement with a leading edge-AI SoC platform company, and multiple additional Bluetooth and Wi-Fi wins across our connectivity portfolio, as well as securing a new customer win with a major U.S.-based MCU provider licensing our next-generation UWB platform.

Across these wins, a clear pattern is emerging. The Bluetooth, NTN and UWB engagements we highlighted this quarter are all with existing customers who have expanded their use of Ceva IP over the past two years. More broadly, customers are increasingly adopting more integrated, system-level solutions from Ceva, expanding our value per design, while strengthening long-term royalty and margin potential.

Licensing and related revenues accounted for 66% of our total revenues for the first quarter of 2026, as compared to 62% for the comparable period of 2025.

29

Table of Contents

Royalty Revenues

Royalty revenues were $9.2 million for the first quarter of both 2026 and 2025. Royalty revenues accounted for 34% of our total revenues for the first quarter of 2026, as compared to 38% for the comparable period of 2025. We continue to see encouraging momentum across our diversified smart edge markets, with growth in IoT, industrial and AI-driven applications. Wi-Fi shipments reached an all-time high in the quarter at 91 million units, up 158% year-over-year, driven by record Wi-Fi 6 volumes, highlighting the continued expansion of this market as customers ramp deployments across a broad range of devices. We are seeing a similar dynamic in Bluetooth, with ongoing adoption of Bluetooth 6 across multiple end markets. Cellular IoT was also strong, coming in at 66 million units, up 38% year-over-year, reflecting broad-based demand across connected devices. More broadly, Wi-Fi and Bluetooth continue to be durable, multi-year growth drivers. AI-driven royalties also continued to grow, highlighted by our first mass-volume automotive AI deployment at Toyota and a ramping AI SoC for surveillance, representing early signs of the long-term contribution we expect from edge AI across multiple end markets. Against these tailwinds, first quarter royalties were impacted by typical seasonal softness in mobile, combined with near-term effects from memory availability constraints and channel inventory in the lower-tier segments. We view these mobile dynamics as largely timing-related and expect improvement as the year progresses, supported by inventory normalization and typical seasonality, along with stronger high-end smartphone demand in the second half.

The five largest royalty-paying customers accounted for 47% of our total royalty revenues for the first quarter of 2026, as compared to 50% for the comparable period of 2025.

Geographic Revenue Analysis

|  | First Quarter 2026 |  |  | First Quarter 2025 |
|  | (in millions, except percentages) |
United States |  | $ | 7.4 |  |  |  | 27 | % |  | $ | 3.6 |  |  |  | 15 | %
Europe and Middle East |  | $ | 1.0 |  |  |  | 4 | % |  | $ | 1.5 |  |  |  | 6 | %
Asia Pacific (1) |  | $ | 18.6 |  |  |  | 69 | % |  | $ | 19.1 |  |  |  | 79 | %
(1) China |  | $ | 15.3 |  |  |  | 56 | % |  | $ | 16.1 |  |  |  | 66 | %

Due to the nature of our license agreements and the associated potential large individual contract amounts, the geographic split of revenues, both in absolute dollars and percentage terms, generally varies from quarter to quarter.

30

Table of Contents

Cost of Revenues

Cost of revenues was $3.7 million for the first quarter of 2026, as compared to $3.5 million for the comparable period of 2025. Cost of revenues accounted for 14% of our total revenues in the first quarter of both 2026 and 2025. The slight increase for the first quarter of 2026 primarily reflected higher payments to the Israeli Innovation Authority of the Ministry of Economy and Industry in Israel. Included in cost of revenues for the first quarter of both 2026 and 2025 was a non-cash equity-based compensation expense of $0.2 million.

Gross Margin

Gross margin for the first quarter of 2026 was 86%, unchanged from 86% for the comparable period of 2025. The increase in gross margin in absolute dollars for the first quarter of 2026 mainly reflected higher licensing and related revenues, as set forth above.

Operating Expenses

Total operating expenses were $28.4 million for the first quarter of 2026, as compared to $25.1 million for the comparable period of 2025. The net increase for the first quarter of 2026 principally reflected higher salaries and employee-related costs, mainly associated with higher currency exchange expenses as a result of the devaluation of the U.S. dollar against the NIS, and higher non-cash equity-based compensation expenses.

Research and Development Expenses, Net

Total research and development expenses, net were $19.8 million for the first quarter of 2026, as compared to $17.6 million for the comparable period of 2025. The increase for the first quarter of 2026 principally reflected higher salaries and employee-related costs, mainly associated with higher currency exchange expenses as a result of the devaluation of the U.S. dollar against the NIS, higher facilities expenses associated with research and development activities and higher non-cash equity-based compensation expenses. Included in research and development expenses for the first quarter of 2026 were non-cash equity-based compensation expenses of $2.9 million, as compared to $2.5 million for the comparable period of 2025. Research and development expenses as a percentage of our total revenues were 73% for the first quarter of both 2026 and 2025.

The number of research and development personnel was 318 at March 31, 2026, as compared to 325 at March 31, 2025.

31

Table of Contents

Sales and Marketing Expenses

Our sales and marketing expenses were $3.8 million for the first quarter of 2026, as compared to $3.4 million for the comparable period of 2025. The increase for the first quarter of 2026 principally reflected higher commission expenses and the cost of a global sales meeting held during the period (an event that did not take place in the first quarter of 2025), partially offset by lower employee-related costs. Included in sales and marketing expenses for the first quarter of 2026 were non-cash equity-based compensation expenses of $0.7 million, as compared to $0.6 million for the comparable period of 2025. Sales and marketing expenses as a percentage of our total revenues were 14% for the first quarter of both 2026 and 2025.

The total number of sales and marketing personnel was 30 at March 31, 2026, as compared to 34 at March 31, 2025.

General and Administrative Expenses

Our general and administrative expenses were $4.7 million for the first quarter of 2026, as compared to $3.9 million for the comparable period of 2025. The increase for the first quarter of 2026 primarily reflected higher salaries and employee-related costs and higher non-cash equity-based compensation expenses. Included in general and administrative expenses for the first quarter of 2026 were non-cash equity-based compensation expenses of $1.6 million, as compared to $1.1 million for the comparable period of 2025. General and administrative expenses as a percentage of our total revenues were 17% for the first quarter of 2026, as compared to 16% for the comparable period of 2025.

The number of general and administrative personnel was 52 at March 31, 2026, as compared to 47 at March 31, 2025.

Amortization of Intangible Assets

Our amortization charges were $0.1 million for the first quarter of both 2026 and 2025. The amortization charges for both periods were incurred in connection with the amortization of intangible assets associated with the acquisitions of the Hillcrest Labs and VisiSonics business.

Financial Income, Net (in millions)

|  | First Quarter 2026 |  |  | First Quarter 2025 |
Financial income, net |  | $ | 1.9 |  |  | $ | 2.1 |
of which: |  |  |  |  |  |  |  |
Interest income and gains and losses from marketable securities, net |  | $ | 2.1 |  |  | $ | 1.5 |
Foreign exchange gain (loss) |  | $ | (0.2 | ) |  | $ | 0.6 |

Financial income, net, consists of interest earned on investments, gains and losses from sale of marketable securities, accretion (amortization) of discounts (premiums) on marketable securities and foreign exchange movements.

The increase in interest income and gains and losses from marketable securities, net, during the first quarter of 2026 principally reflected higher combined bank deposits and marketable securities balances held (mainly resulting from the follow‑on offering completed in the fourth quarter of 2025).

We review our monthly expected major non-U.S. dollar denominated expenditures and look to hold equivalent non-U.S. dollar cash balances to mitigate currency fluctuations. However, our Euro cash balances have increased significantly on a quarterly basis beyond our Euro liabilities, mainly from applicable French research tax credits, which are generally refunded every three years. Separately, our NIS liabilities are significantly higher than our NIS‑denominated assets, mainly because of operating lease obligations. This has resulted in a foreign exchange loss of $0.2 million for the first quarter of 2026, as compared to a foreign exchange gain of $0.6 million for the comparable period of 2025.

Remeasurement of Marketable Equity Securities

We recorded a gain of $0.1 million for the first quarter of 2026, as compared to a loss of $0.1 million for the comparable period of 2025, related to remeasurement of marketable equity securities, which we hold at fair value. Over time, other income (expense), net, may be affected by market dynamics and other factors. Equity values generally change daily for marketable equity securities and upon the occurrence of observable price changes or upon impairment of marketable equity securities. In addition, volatility in the global economic climate and financial markets could result in a significant change in the value of our investments.

32

Table of Contents

Income Tax Expense

Our income tax expenses was $1.3 million for the first quarter of 2026, as compared to $1.0 million for the comparable period of 2025. The increase for the first quarter of 2026 primarily reflected higher withholding tax expenses.

We are subject to income and other taxes in the United States and in numerous foreign jurisdictions. Our domestic and foreign tax liabilities are dependent on the jurisdictions in which profits are determined to be earned and taxed. Additionally, the amount of taxes paid is subject to our interpretation of applicable tax laws in the jurisdictions in which we operate. A number of factors influence our effective tax rate, including changes in tax laws and treaties as well as the interpretation of existing laws and rules. Federal, state, and local governments and administrative bodies within the United States, and other foreign jurisdictions have implemented, or are considering, a variety of broad tax, trade, and other regulatory reforms that may impact us. On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted. Key corporate tax provisions of OBBBA include the restoration of 100% bonus depreciation, immediate expensing for domestic research and experimental expenditures, changes to Section 163(j) interest limitations, modification of several international tax provisions, and expanded Section 162(m) aggregation requirements. In accordance with ASC 740, we have recognized the effects of the new tax law in the period of enactment. The OBBBA did not have a material impact on our financial position.

We have significant operations in Israel and France, and a substantial portion of our taxable income is generated in these jurisdictions, as well as potentially in the U.S. due to Global Intangible Low-Taxed Income and the requirement to capitalize research and development expenditures under IRC Section 174 over 15 years if sourced internationally. Although certain of our non-U.S. subsidiaries are taxed at rates substantially lower than U.S. tax rates, our overall tax rate could nevertheless result in a substantial increase as a result of withholding tax expenses with respect to which we are unable to obtain a refund from the relevant tax authorities.

Our Irish subsidiary qualified for a 12.5% tax rate on its trade. Interest income generated by our Irish subsidiary is taxed at a rate of 25%.

Our French subsidiary is entitled to a tax benefit of 10% applied to specific revenues under the French IP Box regime. The French IP Box regime applies to net income derived from the licensing, sublicensing or sale of several IP rights, such as patents and copyrighted software, including royalty revenues. This elective regime requires a direct link between the income benefiting from the preferential treatment and the research and development expenditures incurred and contributing to that income. Qualifying income may be taxed at a favorable 10% CIT rate (plus social surtax, hence 10.3% in total). Income not eligible for a tax benefit under the French IP Box regime is taxed at a regular rate of 25%.

Our Israeli subsidiary has previously benefited from various Israeli tax incentives, including reduced corporate tax rates and, in some instances, exemptions on undistributed profits. These tax-exempt profits are permanently reinvested as management has determined that the Israeli subsidiary does not currently intend to distribute dividends. Therefore, deferred taxes have not been provided for such tax-exempt income. We intend to continue to reinvest these profits and do not currently foresee a need to distribute dividends out of such tax-exempt income.

Critical Accounting Policies and Estimates

Our consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results could differ from these estimates.

33

Table of Contents

We believe that the assumptions and estimates associated with revenue recognition, equity-based compensation and credit losses have the greatest potential impact on our consolidated financial statements. Therefore, we consider these to be our critical accounting policies and estimates.

See our Annual Report on Form 10-K for the year ended December 31, 2025 for a discussion of additional critical accounting policies and estimates. There have been no changes in our critical accounting policies as compared to those previously disclosed in the Annual Report on Form 10-K for the year ended December 31, 2025.

LIQUIDITY AND CAPITAL RESOURCES

As of March 31, 2026, we had approximately $21.4 million in cash and cash equivalents, $5.1 million in bank deposits, and $189.2 million in marketable securities, totaling $215.7 million, as compared to $222.0 million at December 31, 2025. The decrease for the first three months of 2026 principally reflected cash used in operating activities and investments in leasehold and equipment for our new offices in Ra’anana, Israel, partially offset by cash proceeds from exercise of stock-based awards.

Out of total cash, cash equivalents, bank deposits and marketable securities of $215.7 million, $114.4 million was held by our foreign subsidiaries. Our intent is to reinvest earnings of our foreign subsidiaries, and our current operating plans do not demonstrate a need to repatriate foreign earnings to fund our U.S. operations. However, if we require additional funds for strategic transactions in the United States, we may need to accrue and pay taxes to repatriate these funds. The determination of the amount of additional taxes related to the repatriation of these earnings is not practicable, as it may vary based on various factors such as the location of the cash and the effect of regulation in the various jurisdictions from which the cash would be repatriated.

During the first three months of 2026, we invested $27.6 million of cash in bank deposits and marketable securities with maturities up to 50 months from the balance sheet date. In addition, during the same period, marketable securities were redeemed for cash amounting to $14.1 million. All our marketable securities are classified as available-for-sale. The purchase and sale or redemption of available-for-sale marketable securities are considered part of investing cash flow. Available-for-sale marketable securities are stated at fair value, with unrealized gains and losses reported in accumulated other comprehensive income (loss), a separate component of stockholders’ equity, net of taxes. Realized gains and losses on sales of investments, as determined on a specific identification basis, are included in the interim condensed consolidated statements of loss. The amount of credit losses recorded for the first three months of 2026 was immaterial. For more information about our marketable securities, see Note 4 to the interim condensed consolidated financial statements for the three months ended March 31, 2026.

Bank deposits are classified as short-term bank deposits and long-term bank deposits. Short-term bank deposits are deposits with maturities of more than three months but no longer than one year from the balance sheet date, whereas long-term bank deposits are deposits with maturities of more than one year as of the balance sheet date. Bank deposits are presented at their cost, including accrued interest, and purchases and sales are considered part of cash flows from investing activities.

Operating Activities

Net cash used in operating activities for the first three months of 2026 was $4.9 million and consisted of net loss of $4.5 million, adjustments for non-cash items of $6.6 million, and changes in operating assets and liabilities of $7.0 million. Adjustments for non-cash items primarily consisted of $0.9 million of depreciation and amortization of intangible assets, $5.4 million of equity-based compensation expenses, and $0.5 million of unrealized foreign exchange loss. The decrease in operating assets and liabilities primarily consisted of an increase in prepaid expenses and other assets of $5.8 million (mainly as a result of payments of a yearly design tool subscription and $1.4 million of unbilled receivables classified as “other long-term assets” in the interim condensed consolidated balance sheets), as well as a decrease in accrued expenses and other payables of $0.9 million and a decrease in accrued payroll and related benefits of $0.8 million (mainly due to partial yearly bonus payments), partially offset by an increase in operating lease liabilities of $0.7 million.

Net cash used in operating activities for the first three months of 2025 was $7.4 million and consisted of net loss of $3.3 million, adjustments for non-cash items of $4.4 million, and changes in operating assets and liabilities of $8.5 million. Adjustments for non-cash items primarily consisted of $0.9 million of depreciation and amortization of intangible assets, and $4.3 million of equity-based compensation expenses, partially offset by $0.2 million of amortization of premiums on available-for-sale marketable securities and $0.6 million of unrealized foreign exchange gain. The decrease in operating assets and liabilities primarily consisted of an increase in trade receivables of $3.5 million, and an increase in prepaid expenses and other assets of $3.7 million (mainly as a result of payment of a yearly design tool subscription), as well as a decrease in deferred revenues of $0.6 million, a decrease in accrued expenses and other payables of $1.1 million, and a decrease in accrued payroll and related benefits of $0.8 million (mainly due to partial yearly bonus payments), partially offset by an increase in trade payables of $1.4 million.

34

Table of Contents

Cash flows from operating activities may vary significantly from quarter to quarter depending on the timing of our receipts and payments. Our ongoing cash outflows from operating activities principally relate to payroll-related costs and obligations under our property leases and design tool licenses. Our primary sources of cash inflows are receipts from our accounts receivable, to some extent, funding from research and development government grants and French research tax credits, and interest earned from our cash, deposits and marketable securities. The timing of receipts of accounts receivable from customers is based upon the completion of agreed milestones or agreed dates as set out in the contracts.

Investing Activities

Net cash used in investing activities for the first three months of 2026 was $15.8 million, compared to $6.2 million of net cash provided by investing activities for the comparable period of 2025. We had a cash outflow of $24.6 million and a cash inflow of $14.1 million with respect to investments in marketable securities during the first three months of 2026, as compared to a cash outflow of $29.1 million and a cash inflow of $35.7 million with respect to investments in marketable securities during the first three months of 2025. For the first three months of 2026, we had an investment of $3.0 million in bank deposits. We had a cash outflow of $2.3 million and $0.3 million during the first three months of 2026 and 2025, respectively, from purchase of property and equipment (the 2026 outflow partially reflects investments in leasehold improvements and equipment for our new offices in Ra’anana, Israel).

Financing Activities

Net cash provided by financing activities for the first three months of 2026 was $1.6 million, as compared to net cash provided by financing activities in the amount of $1.4 million for the comparable period of 2025. All of the cash inflows in both periods resulted from the exercise of stock‑based awards.

In August 2008, we announced that our board of directors approved a share repurchase program for up to one million shares of common stock, which was extended collectively by an additional 7,800,000 shares in 2010, 2013, 2014, 2018, 2020, 2023 and 2024. No shares of common stock were repurchased during the first quarter of either 2026 or 2025. As of March 31, 2026, we had 684,486 shares available for repurchase.

We believe that our cash and cash equivalents, short-term bank deposits and marketable securities, along with cash from operations, will provide sufficient capital to fund our operations for at least the next 12 months. We cannot provide assurances, however, that the underlying assumed levels of revenues and expenses will prove to be accurate.

In addition, as part of our business strategy, we occasionally evaluate potential acquisitions of businesses, products and technologies and minority equity investments. Accordingly, a portion of our available cash may be used at any time for the acquisition of complementary products or businesses or minority equity investments. Such potential transactions may require substantial capital resources, which may require us to seek additional debt or equity financing. We cannot assure you that we will be able to successfully identify suitable acquisition or investment candidates, complete acquisitions or investments, integrate acquired businesses into our current operations, or expand into new markets. Furthermore, we cannot provide assurances that additional financing will be available to us in any required time frame and on commercially reasonable terms, if at all.

Contractual Obligations and Commitments

We believe that our contractual obligations and commitments have not changed materially from those included in our Annual Report on Form 10-K for the year ended December 31, 2025.

Item 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

A majority of our revenues and a portion of our expenses are transacted in U.S. dollars and our assets and liabilities together with our cash holdings are predominately denominated in U.S. dollars. However, the majority of our expenses are denominated in currencies other than the U.S. dollar, principally the NIS and the Euro. Increases in volatility of the exchange rates of currencies other than the U.S. dollar versus the U.S. dollar could have an adverse effect on the expenses and liabilities that we incur when remeasured into U.S. dollars. We review our monthly expected non-U.S. dollar denominated expenditures and look to hold equivalent non-U.S. dollar cash balances to mitigate currency fluctuations. However, our Euro cash balances increase significantly on a quarterly basis beyond our Euro liabilities, mainly from French research tax benefits applicable to the CIR, which is generally refunded every three years. Separately, our NIS liabilities are significantly higher than our NIS‑denominated assets, mainly because of operating lease obligations. This has resulted in a foreign exchange loss of $0.2 million for the first quarter of 2026, as compared to a foreign exchange gain of $0.6 million for the comparable period of 2025.

35

Table of Contents

As a result of currency fluctuations and the remeasurement of non-U.S. dollar denominated expenditures to U.S. dollars for financial reporting purposes, we may experience fluctuations in our operating results on an annual and quarterly basis. To protect against the increase in value of forecasted foreign currency cash flow resulting from salaries paid in currencies other than the U.S. dollar during the year, we follow a foreign currency cash flow hedging program. We hedge portions of the anticipated payroll for our non-U.S. employees denominated in currencies other than the U.S. dollar for a period of one to twelve months with forward and option contracts. During the first quarter of 2026 and 2025, we recorded accumulated other comprehensive loss of $0.1 million and $0.4 million, respectively, from our forward and option contracts, net of taxes, with respect to anticipated payroll expenses for our non-U.S. employees. As of March 31, 2026, the amount of other comprehensive loss from our forward and option contracts, net of taxes, was $0.03 million, which will be recorded in the consolidated statements of income (loss) during the following three months. We recognized a net gain of $0.1 million for both the first quarter of 2026 and 2025 related to forward and options contracts. We note that hedging transactions may not successfully mitigate losses caused by currency fluctuations. We expect to continue to experience the effect of exchange rate and currency fluctuations on an annual and quarterly basis.

A hypothetical 10% weakening of the U.S. dollar against the NIS and the Euro would have resulted in an increase to our salary and employee related expenses, which are a large portion of our operating costs, of approximately $1.6 million for the first quarter of 2026. A hypothetical 10% strengthening of the U.S. dollar against the NIS and the Euro would have resulted in a decrease to our salary and employee related expenses of approximately $1.3 million for the first quarter of 2026.

The majority of our cash and cash equivalents are invested in high-grade certificates of deposits with major U.S., European and Israeli banks. Generally, cash and cash equivalents and bank deposits may be redeemed and therefore minimal credit risk exists with respect to them. Nonetheless, deposits with these banks exceed the Federal Deposit Insurance Corporation (FDIC) insurance limits or similar limits in foreign jurisdictions, to the extent such deposits are even insured in such foreign jurisdictions. While we monitor on a systematic basis the cash and cash equivalent balances in the operating accounts and adjust the balances as appropriate, these balances could be impacted if one or more of the financial institutions with which we deposit our funds fails or is subject to other adverse conditions in the financial or credit markets. To date, we have experienced no loss of principal or lack of access to our invested cash or cash equivalents; however, we can provide no assurance that access to our invested cash and cash equivalents will not be affected if the financial institutions that we hold our cash and cash equivalents fail.

We hold an investment portfolio consisting principally of corporate bonds. We have the ability to hold such investments until recovery of temporary declines in market value or maturity. As of March 31, 2026, the unrealized losses associated with our investments were $0.7 million. As we tend to hold such bonds with unrealized losses to recovery, the allowance for credit losses was not material during the first three months of 2026. However, we can provide no assurance that we will recover present declines in the market value of our investments.

Interest income and gains and losses from marketable securities, net, were $2.1 million for the first quarter of 2026, as compared to $1.5 million for the comparable period of 2025. The increase in interest income and gains and losses from marketable securities, net, during the first quarter of 2026 principally reflected higher combined bank deposits and marketable securities balances held (mainly resulting from the follow‑on offering completed in the fourth quarter of 2025).

We are exposed primarily to fluctuations in the level of U.S. interest rates. To the extent that interest rates rise, fixed interest investments may be adversely impacted, whereas a decline in interest rates may decrease the anticipated interest income for variable rate investments. We typically do not attempt to reduce or eliminate our market exposures on our investment securities because the majority of our investments are short term. We currently do not have any derivative instruments but may put them in place in the future. Fluctuations in interest rates within our investment portfolio have not had, and we do not currently anticipate such fluctuations will have, a material effect on our financial position on an annual or quarterly basis.

Item 4. | CONTROLS AND PROCEDURES

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2026.

There has been no change in our internal control over financial reporting that occurred during our most recent fiscal quarter that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.

PART II OTHER INFORMATION

Item 1. | LEGAL PROCEEDINGS

We are subject to legal proceedings and claims that have not been fully resolved and that have arisen in the ordinary course of business. As of March 31, 2026, our interim condensed consolidated balance sheet includes a provision of approximately $0.1 million for these matters. We are not a party to any other litigation or legal proceedings that we believe could reasonably be expected to have a material effect on our business, results of operations and financial condition.

36

Table of Contents

Item 1A. | RISK FACTORS

We have not identified any material changes to the Risk Factors previously disclosed in Part I—Item 1A—“Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, any one or more of which could, directly or indirectly, cause our actual financial condition and operating results to vary materially from past, or from anticipated future, financial condition and operating results. Any of those factors, in whole or in part, could materially and adversely affect our business, financial condition, operating results and stock price. You should carefully consider the risks and uncertainties described in our Annual Report filed on Form 10-K for the year ended December 31, 2025, together with all of the other information in this Quarterly Report on Form 10-Q, including in Part I—Item 2—“Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the condensed consolidated financial statements and related notes.

37

Table of Contents

Item 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There were no repurchases of our common stock during the three months ended March 31, 2026.

Item 3. | DEFAULTS UPON SENIOR SECURITIES

Not applicable.

Item 4. | MINE SAFETY DISCLOSURES

Not applicable.

Item 5. | OTHER INFORMATION

During the three months ended March 31, 2026, no director or officer (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended) of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

38

Table of Contents

Item 6. | EXHIBITS

Exhibit No. | Description
31.1 | Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.
31.2 | Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.
32 | Section 1350 Certification of Chief Executive Officer and Chief Financial Officer.
101.INS | The following materials from Ceva, Inc.’s Quarterly report on Form 10-Q for the quarter ended March 31, 2026, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Statements of Loss, (ii) Condensed Consolidated Balance Sheets, (iii) Condensed Consolidated Statements of Cash Flows, (iv) Condensed Consolidated Statements of Comprehensive Loss, (v) Condensed Consolidated Statements of Changes in Stockholders’ Equity, and (vi) Notes to Condensed Consolidated Financial Statements.
101.SCH | Inline XBRL Taxonomy Extension Schema Document.
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| Ceva, Inc.
Date: May 11, 2026 | By: /s/ AMIR PANUSH
| Amir Panush Chief Executive Officer (principal executive officer)
Date: May 11, 2026 | By: /s/ YANIV ARIELI
| Yaniv Arieli Chief Financial Officer (principal financial officer and principal accounting officer)

39